{"gene":"HNF1B","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":1991,"finding":"HNF1B (vHNF1/LFB3) forms heterodimers with HNF1 (HNF1α) both in vitro and in nuclear extracts of kidney, liver, and cell lines; it also transactivates the albumin promoter in transfection experiments, establishing it as a transcriptional activator.","method":"In vitro heterodimerization assay, nuclear extract biochemical characterization, transfection/transactivation assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro reconstitution of heterodimerization plus functional transactivation assay, replicated independently by two labs (PMID:1673926 and PMID:1673925) in the same year","pmids":["1673926","1673925"],"is_preprint":false},{"year":1991,"finding":"LFB3/HNF1B binds DNA as a dimer and forms heterodimers with LFB1 (HNF1α) both in vitro and in vivo; it acts as a transcriptional activator.","method":"DNA binding assays, in vitro and in vivo heterodimerization, transcriptional activation assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — independent replication of heterodimerization and transactivation by a second lab, consistent with PMID:1673926","pmids":["1673925"],"is_preprint":false},{"year":1996,"finding":"The vHNF1 promoter is transactivated by orphan receptors COUP-TF1/Ear3 and COUP-TFII/Arp1 via an indirect mechanism involving an interaction between COUP-TFI/Ear3 and octamer-binding proteins; a proximal octamer site (not the DR-1 site) is required for this transactivation. HNF4 has virtually no effect on the vHNF1 promoter, unlike the HNF1α promoter.","method":"Promoter deletion analysis, DNA-protein interaction (gel shift/footprinting), transfection/transactivation assays, mammalian two-hybrid interaction assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal methods (footprinting, reporter assays, protein interaction) in a single rigorous study","pmids":["8622679"],"is_preprint":false},{"year":1997,"finding":"HNF1B (vHNF1) protein exists in vivo as two isoforms of ~65 and ~68 kDa, revealing differential post-translational modification compared to HNF1α, which appears as a heterogeneous mixture of 92–98 kDa polypeptides (higher than predicted from sequence).","method":"Polyclonal and monoclonal antibody characterization of liver and kidney extracts (western blot/immunoprecipitation)","journal":"Biochimie","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — antibody-based detection of isoforms in tissue extracts; single lab but multiple antibody reagents confirming differential modification","pmids":["9523012"],"is_preprint":false},{"year":1998,"finding":"LFB3/HNF1B binds to the C domain of a cAMP-responsive enhancer of the urokinase-type plasminogen activator gene in LLC-PK1 kidney cells and cooperates with CREB/ATF1 proteins to mediate cAMP induction; the region of LFB3 between amino acids 400–450 mediates interaction with CREB/ATF1, and deletion of this region abolishes cAMP induction but not basal transactivation on the albumin promoter.","method":"Mutation analysis, transfection assay, mammalian two-hybrid system, domain deletion analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — functional domain mapping by deletion mutagenesis combined with protein–protein interaction assay and reporter assay, single lab with multiple orthogonal methods","pmids":["9671480"],"is_preprint":false},{"year":1999,"finding":"Homozygous inactivation of vHNF1/HNF1B in mice results in embryonic lethality by day 7.5 with disorganized visceral endoderm; vHNF1 expression is essential for visceral endoderm differentiation and is part of a genetic network directing HNF4 and downstream endodermal gene expression. The lethal phenotype is cell-autonomous to the visceral endoderm.","method":"Homologous recombination knockout mouse, ES cell differentiation, tetraploid morula aggregation (complementation), in situ hybridization of marker genes","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined cellular phenotype, tetraploid complementation to establish cell autonomy, multiple marker genes analyzed","pmids":["10518495"],"is_preprint":false},{"year":2001,"finding":"In zebrafish, vhnf1 loss-of-function causes kidney cysts, underdevelopment of pancreas and liver, and otic vesicle defects by disrupting regional patterning; vhnf1 directly regulates expression of pdx1 and shh in gut endoderm, pax2 and wt1 in pronephric primordia, and valentino (val) in hindbrain. Overexpression of vhnf1 expands the val expression domain, demonstrating direct epistatic control.","method":"Insertional mutagenesis screen (zebrafish), mRNA overexpression, in situ hybridization of target genes, genetic epistasis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function and gain-of-function with defined molecular targets across multiple organs, with overexpression rescue","pmids":["11731484"],"is_preprint":false},{"year":2002,"finding":"Hepatocyte/bile-duct-specific deletion of HNF1B in mice causes failure of intrahepatic bile duct morphogenesis, gallbladder abnormalities, and loss of hepatocyte-specific target genes involved in bile acid sensing and fatty acid oxidation, establishing an essential role of HNF1B in bile system morphogenesis and hepatocyte metabolic gene regulation.","method":"Cre/loxP conditional knockout (hepatocyte/bile duct-specific), histology, gene expression analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — tissue-specific conditional KO with defined morphological and molecular phenotype, identification of hepatocyte-specific target genes","pmids":["11934849"],"is_preprint":false},{"year":2003,"finding":"vHNF1/HNF1B directly binds the Kreisler (MafB/val) regulatory element S5 in rhombomere 5/6, and this binding site is essential (but not sufficient) for r5/r6-specific Kreisler expression in early embryos; vHNF1 acts with additional transcription factors to initiate Kreisler expression, establishing direct transcriptional control of hindbrain segmentation.","method":"Transgenic reporter (S5 regulatory element), site-directed mutagenesis of vHNF1-binding site, evolutionary sequence conservation analysis","journal":"Mechanisms of development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic enhancer assay with mutagenesis of binding site, single lab","pmids":["16274963"],"is_preprint":false},{"year":2003,"finding":"vHNF1 (zebrafish) promotes r5+r6 identity through obligate synergy with FGF signals to activate valentino and krox20, and independently represses hoxb1a expression; these are two functionally separable activities of vhnf1 in subdividing the caudal hindbrain.","method":"Zebrafish genetic analysis, FGF pathway inhibition, in situ hybridization, epistasis experiments","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic dissection of two independent molecular activities with pathway inhibition, replicated in related studies (PMID:15342476)","pmids":["12835397"],"is_preprint":false},{"year":2003,"finding":"In embryonic pancreas, Hnf1beta+ cells (ductal cells) are the immediate precursors of Ngn3+ endocrine precursor cells; Hnf1beta expression is markedly reduced in early pancreatic epithelium of Hnf6-deficient mice (in which Ngn3+ cell formation is defective), placing Hnf1b downstream of Hnf6 in a genetic hierarchy controlling endocrine cell generation.","method":"Immunohistochemistry, genetic epistasis (Hnf6 KO mice), co-localization/lineage analysis","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis in KO mice combined with cellular co-localization; single lab","pmids":["14570708"],"is_preprint":false},{"year":2004,"finding":"HNF1B/TCF2 mutations causing MODY5 impair transactivation through two distinct mechanisms: (1) loss of DNA-binding capacity, or (2) retention of DNA binding but loss of association with histone acetyltransferases CBP and PCAF. Wild-type HNF1β transactivation depends on synergistic action of CBP and PCAF; truncation mutations causing defective nuclear localization show weak dominant-negative activity; the C-terminal QSP-rich domain is required for full transactivation.","method":"In vitro mutagenesis, transfection/reporter assay, co-immunoprecipitation with CBP/PCAF, nuclear localization studies, HDAC inhibitor (TSA) treatment","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (mutagenesis, Co-IP, reporter assay, drug treatment) characterizing multiple disease mutations, single lab with rigorous mechanistic follow-up","pmids":["15509593"],"is_preprint":false},{"year":2004,"finding":"vHNF1/HNF1B integrates retinoic acid (RA) signals and FGF signals in hindbrain patterning: RA induces val expression via activation of vhnf1; FGF signals from r4 (through MAPK pathway) then cooperate with Vhnf1 to activate val and specify r5/r6. vhnf1 acts largely independently of val to repress r4 identity in the posterior hindbrain.","method":"Zebrafish genetic analysis, RA treatment, FGF pathway manipulation, MAPK pathway analysis, in situ hybridization, epistasis experiments","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — pathway dissection using genetic and pharmacological approaches with clear epistatic ordering, replicated across multiple hindbrain studies","pmids":["15342476"],"is_preprint":false},{"year":2005,"finding":"Tcf2/vHNF1 is essential for early pancreas development; Tcf2-null mice (rescued from early lethality by tetraploid aggregation) exhibit pancreas agenesis by E13.5. The dorsal bud rudiment that forms transiently expresses Ipf1 and Hlxb9 but lacks Ptf1a and endocrine precursor cells. Tcf2 also controls regional specification of gut (ectopic Shh, loss of Ihh/Ipf1 in posterior stomach/duodenum), establishing epistatic control of Ptf1a and gut patterning genes.","method":"Tetraploid embryo aggregation rescue of null embryos, in situ hybridization of key transcription factors, immunohistochemistry","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional rescue of early-lethal KO by tetraploid aggregation, multiple molecular targets validated by in situ hybridization","pmids":["15668393"],"is_preprint":false},{"year":2005,"finding":"HNF1B directly regulates the Pkhd1 promoter in kidney; HNF1B mutant mice show decreased Pkhd1 expression and develop renal cysts, linking MODY5/HNF1B-associated cystic kidney disease to downregulation of the ARPKD gene PKHD1.","method":"Transgenic mice with kidney-specific mutant HNF1B, Cre/loxP kidney-specific deletion, promoter binding/ChIP for Pkhd1, gene expression analysis","journal":"Kidney international","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct promoter regulation shown in two independent mouse models (transgenic mutant + conditional KO) with molecular validation","pmids":["16221171"],"is_preprint":false},{"year":2005,"finding":"HNF1β target genes identified in HEK293 kidney cells include DPP4, ACE2, and osteopontin (SPP1), which contain functional HNF1 binding sites in their promoters and are directly regulated; nine of 25 identified target genes are deregulated in ovarian clear cell carcinoma.","method":"Conditional HNF1B expression system (Flp recombinase, tetracycline-inducible), oligonucleotide microarray, promoter analysis for HNF1 binding sites","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide expression profiling with conditional expression system and promoter binding site validation; single lab","pmids":["16297991"],"is_preprint":false},{"year":2006,"finding":"In zebrafish, Bmp signaling is required for vhnf1 expression in endoderm (Bmp pathway activation expands, Bmp pathway loss reduces vhnf1); Fgf signaling regulates pancreas development through the vhnf1 pathway; vhnf1 acts downstream of RA, Bmp, and Fgf signals to regulate endocrine beta cell development. RA cannot rescue vhnf1 mutant insulin defects, but vhnf1 overexpression restores insulin expression blocked by RA receptor inhibition.","method":"Morpholino knockdown (chordin, alk8), FGF pathway inhibition, RA receptor inhibitor, mRNA overexpression rescue, in situ hybridization, genetic epistasis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple pathway manipulations with epistasis ordering, rescue experiments; consistent with independent zebrafish hindbrain studies","pmids":["17217944"],"is_preprint":false},{"year":2006,"finding":"vHNF1/TCF2 (acting upstream) activates HNF6 expression through a functional HNF1-binding site in an intronic enhancer of Hnf6; this establishes a vHNF1→HNF6→Pdx1 sequential cascade controlling generation of pancreatic precursor cells in the endoderm.","method":"In vitro protein-DNA interaction, endoderm electroporation reporter assay, transgenesis, gene inactivation, Hnf6 KO mice, Tcf2 KO mice","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct protein-DNA binding combined with multiple in vivo models (electroporation, transgenesis, KO) confirming vHNF1→HNF6 epistatic relationship","pmids":["16380477"],"is_preprint":false},{"year":2007,"finding":"HNF1β directly binds the SOCS3 promoter and represses SOCS3 transcription in kidney epithelial cells. In HNF1β knockout mice and cells expressing dominant-negative HNF1β, increased SOCS3 inhibits HGF-induced tubulogenesis by decreasing phosphorylation of ERK and STAT3. Knockdown of SOCS3 in dominant-negative HNF1β-expressing cells rescues tubulogenesis by restoring ERK and STAT3 phosphorylation.","method":"Genome-wide ChIP-chip (chromatin immunoprecipitation + microarray), mRNA microarray, HNF1β knockout mouse, dominant-negative HNF1β cell line, SOCS3 knockdown rescue, tubulogenesis assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — genome-wide ChIP identifies direct target, KO mouse validates in vivo, siRNA rescue with defined signaling readouts (ERK/STAT3 phosphorylation)","pmids":["18077349"],"is_preprint":false},{"year":2007,"finding":"A conserved 800-bp enhancer in intron 4 of vHnf1 recapitulates its neural expression pattern in transgenic mice; functional analysis identifies two essential motif types: a retinoic acid response element and two half T-MARE sites, demonstrating direct integration of RA signaling and MAF-related factor inputs into vHnf1 expression. MAFB, itself regulated by vHNF1, acts as a positive modulator of vHnf1 in r5/r6 (feedback loop).","method":"Transgenic enhancer reporter mice, site-directed mutagenesis of RARE and T-MARE sites","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — transgenic reporter with mutagenesis of cis-regulatory elements, single lab but in vivo validation","pmids":["17669392"],"is_preprint":false},{"year":2008,"finding":"HNF1β interacts physically with five novel protein partners (including E4F1 and ZFP36L1) identified by bacterial two-hybrid screen using the N-terminal region of HNF1B, with four confirmed by GST pull-down. ZFP36L1, predominantly cytoplasmic, can reduce HNF1β transactivation in a luciferase reporter system. E4F1 co-localizes with HNF1β in the nucleus.","method":"Bacterial two-hybrid screen, GST pull-down confirmation, luciferase reporter assay, co-localization by immunofluorescence, Xenopus overexpression for phenotypic validation","journal":"Kidney international","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — bacterial two-hybrid + GST pull-down for interaction identification with functional reporter assay; single lab","pmids":["18418350"],"is_preprint":false},{"year":2008,"finding":"vHNF1 (HNF1B) is required cell-autonomously for hepatic specification; loss of vHnf1 in mouse ventral endoderm blocks thickening, expression of hepatic genes, and responsiveness to inductive FGF signals in vitro. In zebrafish, the same conserved role is confirmed, establishing vHNF1 as required for endoderm competence and hepatic specification.","method":"Tetraploid complementation (vHnf1 KO mouse), in vitro culture of mutant ventral endoderm with FGF, zebrafish knockdown, in situ hybridization of hepatic specification markers (albumin, transthyretin)","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — combined mouse (KO rescued by tetraploid aggregation) and zebrafish models with in vitro FGF responsiveness assay, multiple molecular markers","pmids":["18635606"],"is_preprint":false},{"year":2009,"finding":"HNF1B directly transactivates the FXYD2 promoter (shown by luciferase reporter assay), and HNF1B mutations associate with hypomagnesemia and renal magnesium wasting, establishing that HNF1B regulates FXYD2 transcription to control tubular Mg2+ handling.","method":"Luciferase reporter assay with HNF1 recognition site in FXYD2 promoter, clinical cohort analysis with plasma magnesium measurements","journal":"Journal of the American Society of Nephrology : JASN","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct promoter transactivation assay with in silico identification of binding site; clinical phenotype supports mechanistic link; single lab","pmids":["19389850"],"is_preprint":false},{"year":2010,"finding":"vHNF1 (HNF1B) controls early kidney development through two distinct regulatory circuits: (1) it regulates ureteric bud (UB) outgrowth and branching morphogenesis in a cell-autonomous manner; (2) it maintains nephric duct epithelium, controls Müllerian duct formation, and regulates early nephrogenesis. vHNF1 directly controls Wnt9b, which acts upstream of mesenchymal-epithelial transitions initiating nephrogenesis.","method":"Conditional (Cre/loxP) and mosaic inactivation of vHnf1 in mouse kidney, in situ hybridization and expression analysis of Wnt9b and other target genes, ChIP for direct target confirmation","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with mosaic analysis to establish cell autonomy, direct target (Wnt9b) validated by ChIP, multiple molecular targets identified","pmids":["20040500"],"is_preprint":false},{"year":2012,"finding":"Compound heterozygous inactivation of Hnf1b and Pax2 in mice produces severe CAKUT phenotypes beyond those of either single heterozygote, revealing Hnf1b as a modifier of Pax2 haploinsufficiency. Compound mutants show delayed nephron segmentation, increased apoptosis, reduced Lim1/Wnt4 expression, and perturbation of ureter smooth muscle differentiation with downregulation of Bmp4 and Tbx18, establishing cooperative roles in kidney and ureter morphogenesis.","method":"Compound heterozygous mouse genetics, in situ hybridization, expression analysis of molecular markers","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis via compound heterozygous mouse model with multiple molecular readouts; single lab","pmids":["22511595"],"is_preprint":false},{"year":2015,"finding":"Conditional inactivation of Hnf1b in mouse pancreas causes: (1) reduced pancreatic multipotent progenitor cell pool due to decreased proliferation and increased apoptosis; (2) cystic ducts with aberrant cell polarity and decreased expression of cystic disease genes; (3) loss/abnormal differentiation of acinar cells; and (4) absence of Ngn3+ endocrine precursors throughout embryogenesis. HNF1B directly occupies putative Ngn3 regulatory sequences in vivo. Glis3 is identified as a novel HNF1B downstream target controlling duct morphogenesis and endocrine development.","method":"Constitutive and inducible conditional Cre/loxP inactivation of Hnf1b at different developmental stages, ChIP (HNF1B occupancy at Ngn3 regulatory sequences), expression analysis, cell proliferation/apoptosis assays","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple conditional KO models at different developmental stages, direct ChIP for Ngn3 regulatory sequences, multiple orthogonal methods","pmids":["25715395"],"is_preprint":false},{"year":2017,"finding":"Specific removal of Hnf1b from the ureteric bud causes defective cell-cell contacts, loss of apicobasal polarity, and decreased cell rearrangements during mitosis-associated cell dispersal, leading to severe epithelial disorganization, mispatterned ureteric tree, and cystogenesis. HNF1B acts both upstream and downstream of Ret signaling by directly regulating Gfra1 and Etv5.","method":"Ureteric bud-specific Cre/loxP conditional KO, high-resolution ex vivo live imaging with membranous fluorescent reporter, mRNA-seq, promoter/binding analysis for Gfra1/Etv5","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific conditional KO with live imaging revealing cellular mechanisms, mRNA-seq, and direct target gene identification","pmids":["29158444"],"is_preprint":false},{"year":2018,"finding":"HNF1β directly represses Twist2 transcription in renal epithelial cells. Loss of HNF1β activates a Twist2-dependent transcriptional network including Snail1, Snail2, and Zeb2 (EMT transcription factors). HNF1β-deficient epithelial cells secrete high levels of TGF-β ligands that activate Smad transcription factors in renal interstitial cells, causing fibrosis through a cell-non-autonomous mechanism (not by direct epithelial-to-myofibroblast transdifferentiation, as shown by lineage tracing).","method":"HNF1β-deficient mIMCD3 cells, RNA-seq, ChIP (direct Twist2 repression), Twist2 knockdown rescue, cell lineage analysis in HNF1β mutant mice","journal":"Journal of the American Society of Nephrology : JASN","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct ChIP demonstrating Twist2 repression, siRNA rescue of fibroblastic phenotype, lineage tracing to establish non-cell-autonomous mechanism, RNA-seq for pathway identification","pmids":["30097458"],"is_preprint":false},{"year":2018,"finding":"ERRγ and HNF1β cooperate to control renal reabsorption through convergent genomic binding; ERRγ directly regulates mitochondrial metabolism and cooperatively controls renal reabsorption via convergent binding with HNF1β. Deletion of ERRγ in renal epithelial cells phenocopies HNF1β loss-of-function, producing overlapping renal transcriptional signatures.","method":"Conditional renal epithelial ERRγ KO mouse, ChIP-seq showing co-occupancy, transcriptomic comparison to HNF1β mutant phenotype","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq demonstrating co-occupancy, KO mouse with phenotypic comparison; interaction with HNF1β not directly confirmed by Co-IP","pmids":["29735694"],"is_preprint":false},{"year":2018,"finding":"HNF1β is a transcriptional activator of the calcium-sensing receptor (CaSR) gene in the thick ascending limb (TAL) of the kidney; a conserved HNF1β binding site in CaSR intron 2 mediates this activation. A DNA-binding-deficient HNF1β mutant (p.Lys156Glu) abolishes CaSR expression. Hnf1β knockdown in TAL cells reduces CaSR and Cldn14 expression and upregulates Cldn10b; kidney-specific HNF1β KO mice show 81% downregulation of Casr.","method":"HNF1β ChIP-seq (binding site identification), luciferase-promoter assay, DNA-binding mutant (p.Lys156Glu), Hnf1β siRNA knockdown in MKTAL cells, kidney-specific HNF1β KO mouse, qRT-PCR","journal":"American journal of physiology. Renal physiology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — ChIP-seq + reporter assay + binding-defective mutant + KO mouse, multiple orthogonal methods in single study","pmids":["29561186"],"is_preprint":false},{"year":2019,"finding":"HNF1B transcriptionally represses SLUG (SNAI2) expression through interaction with RBBP7/RbAP46, and this repression suppresses EMT. EZH2 directly binds the HNF1B locus and suppresses HNF1B expression in prostate cancer cells, establishing an EZH2→HNF1B→SLUG axis regulating EMT.","method":"ChIP-seq (HNF1B promoter binding by EZH2; HNF1B target gene binding), RNA-seq, Co-IP (HNF1B–RBBP7 interaction), luciferase reporter for SLUG, overexpression/knockdown cell assays, clinical correlation","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq plus Co-IP for RBBP7 interaction, with functional EMT assays; single lab","pmids":["31636385"],"is_preprint":false},{"year":2021,"finding":"MafA, NeuroD1, and HNF1β synergistically activate the Slc2a2 (Glut2) gene in β-cells through simultaneous binding to both the proximal promoter and a distal enhancer (ECR3') ~40 kb downstream. Co-immunoprecipitation suggests MafA, NeuroD1, and HNF1β physically interact with each other; simultaneous HNF1β binding to both regulatory elements is indispensable for transcriptional activation.","method":"Luciferase reporter assay, co-immunoprecipitation (MafA–NeuroD1–HNF1β complex), ChIP-seq data re-analysis, mutagenesis of binding sites","journal":"Journal of molecular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for protein interaction, reporter assays with binding site mutagenesis; single lab","pmids":["34223824"],"is_preprint":false},{"year":2022,"finding":"HNF1B is essential for reprogramming mouse fibroblasts to induced renal tubular epithelial cells (iRECs) and for inducing ectopic pronephric tissue in Xenopus ectodermal organoids. The patient mutation R295C retains overall reprogramming capacity but selectively alters expression of specific downstream target gene sets rather than globally reducing HNF1β transcriptional activity. Cross-species conserved HNF1B transcriptional targets are dysregulated in hnf1b CRISPR-depleted Xenopus embryos.","method":"Direct reprogramming of mouse fibroblasts, Xenopus ectodermal explant assay, bulk RNA-seq (wild-type vs. R295C mutant), CRISPR/Cas9 in Xenopus","journal":"Journal of the American Society of Nephrology : JASN","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — two independent experimental systems (fibroblast reprogramming + Xenopus organoid), patient mutation functional characterization, CRISPR validation in vivo","pmids":["36522156"],"is_preprint":false},{"year":2022,"finding":"The HNF1αp291fsinsC truncation (MODY3) interacts with HNF1β and inhibits its function in pancreatic progenitor differentiation; disrupting the HNF1α–HNF1β interaction partially rescues HNF1β-dependent transcription. HNF1β overexpression in the HNF1αp291fsinsC background increases PDX1+ progenitors and partially rescues β cell differentiation.","method":"hiPSC-derived 3D organoids, CRISPR/Cas9 engineering, Co-IP (HNF1αp291fsinsC–HNF1β interaction), HNF1β overexpression rescue, flow cytometry for progenitor markers","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — Co-IP demonstrating physical interaction, organoid rescue experiments with HNF1β overexpression; multiple orthogonal methods in single rigorous study","pmids":["35235779"],"is_preprint":false},{"year":2023,"finding":"Müllerian duct-specific ablation of Hnf1b in mice causes hypoplastic uterine development and kidney anomalies, mirroring Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome type II. Single-cell RNA sequencing of uterine tissue from Hnf1b-ablated embryos reveals dysregulation of cell proliferation, migration, and differentiation pathways downstream of Hnf1b.","method":"Müllerian duct epithelium-specific Cre/loxP conditional KO, single-cell RNA sequencing, microarray analysis of patient material","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific conditional KO with defined phenotype plus scRNA-seq pathway analysis; establishes causal mechanism for MRKH","pmids":["36282544"],"is_preprint":false}],"current_model":"HNF1B (vHNF1/TCF2/LFB3) is a POU-homeodomain transcription factor that forms homodimers and heterodimers with HNF1α, recruits the histone acetyltransferases CBP and PCAF for transactivation, and directly binds the promoters and enhancers of a broad set of target genes (including FXYD2, CaSR, PKHD1, SOCS3, Twist2, Ngn3, Wnt9b, Gfra1, Etv5, Slc2a2/GLUT2, HNF6, Kreisler/MafB, and others) to control epithelial morphogenesis, cell polarity, tubulogenesis, and metabolic gene programs in kidney, liver, pancreas, and other epithelia during development and adult homeostasis; its loss derepresses SOCS3 (blocking HGF-ERK/STAT3-mediated tubulogenesis), activates a Twist2-TGFβ fibrotic cascade, and disrupts Wnt, FGF, and RA signaling hierarchies essential for organogenesis."},"narrative":{"mechanistic_narrative":"HNF1B (vHNF1/TCF2/LFB3) is a homeodomain transcription factor that orchestrates epithelial morphogenesis, cell polarity, and metabolic gene programs across endoderm- and mesoderm-derived organs during development and adult homeostasis [PMID:10518495, PMID:20040500]. It binds DNA as a dimer and forms heterodimers with HNF1α, acting as a sequence-specific transcriptional activator [PMID:1673926, PMID:1673925]; full transactivation depends on its C-terminal QSP-rich domain and on recruitment of the histone acetyltransferases CBP and PCAF, and MODY5-causing mutations abolish activity either by destroying DNA binding or by uncoupling the factor from these coactivators [PMID:15509593]. As a developmental master regulator HNF1B sits atop sequential transcriptional cascades — it directly activates Hnf6 (driving an Hnf6→Pdx1 axis), occupies Ngn3 regulatory sequences, and is required for visceral endoderm differentiation, hepatic specification, and pancreatic progenitor formation [PMID:10518495, PMID:16380477, PMID:18635606, PMID:25715395]; in the hindbrain it integrates retinoic acid, FGF, and Bmp inputs to activate Kreisler/MafB (val) and specify rhombomeres 5/6 [PMID:16274963, PMID:15342476, PMID:17217944, PMID:17669392]. In the kidney and genitourinary tract HNF1B controls ureteric bud branching, apicobasal polarity, and nephrogenesis by directly regulating Wnt9b, Gfra1, and Etv5 in the Ret pathway, and its Müllerian-duct function underlies a MRKH-like phenotype [PMID:20040500, PMID:29158444, PMID:36282544]. It directly governs renal transport genes including FXYD2, the calcium-sensing receptor (CaSR), and PKHD1, linking its loss to hypomagnesemia, disordered calcium handling, and cystic kidney disease [PMID:16221171, PMID:19389850, PMID:29561186]. HNF1B loss is also pathogenic through derepression of normally silenced targets: it represses SOCS3 (whose derepression blocks HGF-driven ERK/STAT3 tubulogenesis) and the EMT regulators Twist2 and SLUG/SNAI2, so that its absence triggers a Twist2–TGFβ fibrotic cascade acting cell-non-autonomously on the interstitium [PMID:18077349, PMID:30097458, PMID:31636385]. Mutations in HNF1B cause MODY5 with associated cystic kidney disease [PMID:15509593, PMID:16221171].","teleology":[{"year":1991,"claim":"Established the basic molecular identity of HNF1B as a dimeric DNA-binding transcriptional activator that heterodimerizes with HNF1α, defining how it engages target promoters.","evidence":"In vitro and nuclear-extract heterodimerization assays plus reporter transactivation of the albumin promoter, independently replicated by two labs","pmids":["1673926","1673925"],"confidence":"High","gaps":["Did not identify in vivo target gene repertoire","Coactivator requirements unresolved","Tissue-specific functions not addressed"]},{"year":1996,"claim":"Defined how HNF1B's own expression is controlled, showing its promoter is driven by COUP-TF orphan receptors via octamer-binding proteins rather than the HNF4 input that governs HNF1α.","evidence":"Promoter deletion, footprinting, reporter and mammalian two-hybrid assays","pmids":["8622679"],"confidence":"High","gaps":["In vivo relevance of COUP-TF regulation not tested","Does not address downstream HNF1B targets"]},{"year":1998,"claim":"Mapped a discrete interaction surface (aa 400–450) through which HNF1B cooperates with CREB/ATF1 for cAMP-responsive transcription, distinguishing inducible from basal transactivation.","evidence":"Domain-deletion mutagenesis, mammalian two-hybrid, and reporter assays in kidney cells","pmids":["9671480"],"confidence":"High","gaps":["Physiological cAMP targets of this interaction not identified","Single cell-line context"]},{"year":1999,"claim":"Showed HNF1B is cell-autonomously essential for visceral endoderm differentiation and sits upstream of HNF4, establishing it as an early endodermal regulator before organogenesis.","evidence":"Knockout mouse with ES-cell differentiation and tetraploid complementation, marker in situ hybridization","pmids":["10518495"],"confidence":"High","gaps":["Early lethality obscured later organ-specific roles","Direct vs indirect control of HNF4 not resolved"]},{"year":2001,"claim":"Demonstrated multi-organ patterning roles by identifying direct/epistatic targets (pdx1, shh, pax2, wt1, valentino) across kidney, pancreas, liver, and hindbrain.","evidence":"Zebrafish insertional mutant plus overexpression with target in situ hybridization and epistasis","pmids":["11731484"],"confidence":"High","gaps":["Direct binding to most targets not shown","Mammalian conservation tested only later"]},{"year":2002,"claim":"Defined HNF1B as essential for intrahepatic bile duct morphogenesis and hepatocyte metabolic gene regulation through tissue-specific deletion.","evidence":"Hepatocyte/bile-duct conditional Cre/loxP knockout with histology and expression profiling","pmids":["11934849"],"confidence":"High","gaps":["Direct target promoters for metabolic genes not mapped","Mechanism of duct morphogenesis defect not resolved"]},{"year":2003,"claim":"Resolved hindbrain segmentation control, showing HNF1B directly binds the Kreisler/MafB S5 element and acts in FGF-dependent synergy to specify r5/r6 while independently repressing r4 identity.","evidence":"Transgenic enhancer reporters with binding-site mutagenesis (mouse) and zebrafish genetic/FGF-inhibition epistasis","pmids":["16274963","12835397"],"confidence":"High","gaps":["Identity of cooperating r5/r6 factors incomplete","Mechanism of hoxb1a repression not defined"]},{"year":2003,"claim":"Placed HNF1B within the pancreatic endocrine hierarchy as a Hnf6-dependent factor in ductal precursors that give rise to Ngn3+ endocrine cells.","evidence":"Immunohistochemistry and lineage/epistasis analysis in Hnf6-deficient mice","pmids":["14570708"],"confidence":"Medium","gaps":["Direct Ngn3 regulation shown only later","Single-lab epistasis"]},{"year":2004,"claim":"Defined the molecular basis of MODY5 mutations, distinguishing DNA-binding loss from coactivator (CBP/PCAF) uncoupling and identifying the QSP-rich domain as required for transactivation.","evidence":"Mutagenesis, reporter assays, Co-IP with CBP/PCAF, nuclear localization studies, TSA treatment","pmids":["15509593"],"confidence":"High","gaps":["Genotype-phenotype correlation for specific tissues not addressed","Coactivator recruitment to endogenous loci not shown"]},{"year":2004,"claim":"Established HNF1B as a signaling integrator that converts RA and FGF/MAPK inputs into hindbrain positional identity.","evidence":"Zebrafish genetics with RA treatment and FGF/MAPK manipulation, in situ hybridization, epistasis","pmids":["15342476"],"confidence":"High","gaps":["Direct vs indirect transcriptional integration not separated","Mammalian relevance not tested here"]},{"year":2005,"claim":"Connected HNF1B to cystic kidney disease mechanistically by showing it directly regulates the Pkhd1/ARPKD promoter, whose downregulation produces renal cysts.","evidence":"Transgenic mutant and conditional KO mouse kidneys with ChIP/promoter binding for Pkhd1","pmids":["16221171"],"confidence":"High","gaps":["Other cystogenic targets not enumerated here","Quantitative contribution of Pkhd1 vs other targets unclear"]},{"year":2005,"claim":"Expanded the direct target catalog (DPP4, ACE2, SPP1) and linked HNF1B targets to ovarian clear cell carcinoma.","evidence":"Conditional inducible expression system, microarray, and promoter binding-site analysis in HEK293 cells","pmids":["16297991"],"confidence":"Medium","gaps":["Cell-line context may not reflect kidney epithelia","Direct binding confirmed only by motif analysis for some targets"]},{"year":2005,"claim":"Showed HNF1B is required for early pancreas development and controls regional gut patterning by acting upstream of Ptf1a and other patterning genes.","evidence":"Tetraploid-aggregation rescue of null embryos with in situ hybridization and immunohistochemistry","pmids":["15668393"],"confidence":"High","gaps":["Direct vs indirect Ptf1a control not resolved here","Mechanism of agenesis (proliferation vs specification) addressed later"]},{"year":2006,"claim":"Defined a direct vHNF1→HNF6→Pdx1 transcriptional cascade controlling pancreatic precursor generation, anchoring HNF1B atop the endocrine differentiation hierarchy.","evidence":"In vitro protein-DNA binding to an Hnf6 intronic enhancer plus electroporation reporters, transgenesis, and Hnf6/Tcf2 KO mice","pmids":["16380477"],"confidence":"High","gaps":["Cofactors at the Hnf6 enhancer not identified","Pdx1 regulation is downstream/indirect"]},{"year":2006,"claim":"Positioned HNF1B downstream of RA, Bmp, and Fgf signals in endoderm to drive endocrine β-cell development, refining its role as a signaling node.","evidence":"Zebrafish morpholino knockdown, pathway inhibition, RA receptor inhibition, and mRNA overexpression rescue","pmids":["17217944"],"confidence":"High","gaps":["Direct transcriptional targets of the integrated signals not mapped","Mammalian validation not in this study"]},{"year":2007,"claim":"Revealed a key derepression mechanism in disease: HNF1B directly represses SOCS3, and its loss derepresses SOCS3 to block HGF-driven ERK/STAT3 tubulogenesis.","evidence":"Genome-wide ChIP-chip, microarray, KO mouse and dominant-negative cells with SOCS3-knockdown rescue and ERK/STAT3 phosphorylation readouts","pmids":["18077349"],"confidence":"High","gaps":["In vivo contribution of SOCS3 derepression to human disease not quantified","Other repressed targets not detailed here"]},{"year":2007,"claim":"Mapped the cis-regulatory logic of HNF1B's neural expression, identifying a RARE and T-MARE-containing enhancer and a MAFB feedback loop reinforcing r5/r6 expression.","evidence":"Transgenic enhancer reporter mice with site-directed mutagenesis of RARE and T-MARE sites","pmids":["17669392"],"confidence":"High","gaps":["Feedback loop dynamics not quantified","Other enhancers controlling non-neural expression not addressed"]},{"year":2008,"claim":"Identified novel HNF1B protein partners (E4F1, ZFP36L1) and showed ZFP36L1 can dampen HNF1B transactivation, hinting at post-translational/cytoplasmic regulation.","evidence":"Bacterial two-hybrid screen, GST pull-down, reporter assay, co-localization, Xenopus overexpression","pmids":["18418350"],"confidence":"Medium","gaps":["Interactions found via bacterial two-hybrid without reciprocal in vivo validation","Physiological significance of partners unclear"]},{"year":2008,"claim":"Established HNF1B as cell-autonomously required for hepatic specification and endoderm competence to respond to inductive FGF.","evidence":"Tetraploid-complemented mouse KO with in vitro FGF responsiveness and zebrafish knockdown, hepatic marker in situ hybridization","pmids":["18635606"],"confidence":"High","gaps":["Direct targets conferring FGF competence not identified","Mechanism linking HNF1B to FGF responsiveness unresolved"]},{"year":2009,"claim":"Linked HNF1B to renal magnesium handling by showing direct FXYD2 promoter transactivation, explaining hypomagnesemia in mutation carriers.","evidence":"Luciferase reporter assay with HNF1 site plus clinical cohort magnesium measurements","pmids":["19389850"],"confidence":"Medium","gaps":["Endogenous ChIP binding not shown","Single-lab clinical association"]},{"year":2010,"claim":"Dissected two HNF1B kidney circuits — ureteric bud branching and nephric/Mullerian duct maintenance — and identified direct control of Wnt9b initiating nephrogenesis.","evidence":"Conditional and mosaic Cre/loxP inactivation with ChIP validation of Wnt9b and expression analysis","pmids":["20040500"],"confidence":"High","gaps":["Full target set of each circuit not enumerated","Mechanism of duct maintenance incompletely defined"]},{"year":2012,"claim":"Revealed HNF1B as a genetic modifier of Pax2 haploinsufficiency, with cooperative control of nephron segmentation and ureter smooth muscle differentiation.","evidence":"Compound heterozygous mouse genetics with molecular-marker in situ hybridization","pmids":["22511595"],"confidence":"High","gaps":["Direct HNF1B-Pax2 molecular interaction not shown","Single-lab study"]},{"year":2015,"claim":"Resolved HNF1B's pancreatic roles at cellular resolution — progenitor proliferation/survival, duct polarity, acinar differentiation, and direct occupancy of Ngn3 regulatory sequences — and identified Glis3 as a downstream target.","evidence":"Stage-specific conditional KO models with ChIP at Ngn3 sequences, expression and proliferation/apoptosis assays","pmids":["25715395"],"confidence":"High","gaps":["Direct vs cofactor-dependent Ngn3 activation not fully resolved","Glis3 regulatory mechanism not detailed"]},{"year":2017,"claim":"Defined the cellular mechanism of HNF1B in epithelial morphogenesis — cell-cell contacts, apicobasal polarity, mitotic cell rearrangement — via direct regulation of Ret-pathway genes Gfra1 and Etv5.","evidence":"Ureteric-bud-specific KO with live ex vivo imaging, mRNA-seq, and binding analysis for Gfra1/Etv5","pmids":["29158444"],"confidence":"High","gaps":["Direct polarity-effector targets not fully mapped","Mechanism coupling transcription to cell rearrangement unresolved"]},{"year":2018,"claim":"Uncovered a cell-non-autonomous fibrotic mechanism: HNF1B directly represses Twist2, and its loss activates a Twist2-EMT network and TGF-β secretion driving interstitial fibrosis without epithelial transdifferentiation.","evidence":"HNF1B-deficient mIMCD3 cells, RNA-seq, ChIP for Twist2, Twist2-knockdown rescue, and lineage tracing in mutant mice","pmids":["30097458"],"confidence":"High","gaps":["Identity of secreted TGF-β ligands not pinned down","In vivo fibrosis contribution quantification limited"]},{"year":2018,"claim":"Showed HNF1B cooperates with ERRγ through convergent genomic binding to control renal reabsorption, linking HNF1B to mitochondrial metabolic gene programs.","evidence":"ERRγ conditional KO mouse, ChIP-seq co-occupancy, and transcriptomic comparison to HNF1B mutants","pmids":["29735694"],"confidence":"Medium","gaps":["Direct HNF1B-ERRγ physical interaction not confirmed by Co-IP","Co-occupancy vs cooperative activity not fully separated"]},{"year":2018,"claim":"Demonstrated direct HNF1B activation of CaSR (and Cldn14) in the thick ascending limb, mechanistically linking HNF1B to renal calcium handling, with a binding-defective mutant abolishing activation.","evidence":"ChIP-seq, reporter assay, DNA-binding mutant p.Lys156Glu, siRNA knockdown in TAL cells, and kidney-specific KO mouse","pmids":["29561186"],"confidence":"High","gaps":["Clinical calcium phenotype in carriers not directly tested here","Regulation of Cldn10b switch mechanism not detailed"]},{"year":2019,"claim":"Identified an EZH2→HNF1B→SLUG axis in cancer, showing HNF1B represses SNAI2/SLUG via RBBP7 to suppress EMT and is itself silenced by EZH2.","evidence":"ChIP-seq, RNA-seq, Co-IP for HNF1B-RBBP7, SLUG reporter, and overexpression/knockdown EMT assays","pmids":["31636385"],"confidence":"Medium","gaps":["Single-lab characterization","In vivo tumor relevance of RBBP7 complex not established"]},{"year":2021,"claim":"Showed HNF1B physically and functionally cooperates with MafA and NeuroD1 to activate Slc2a2/Glut2 in β-cells via simultaneous binding to promoter and distal enhancer.","evidence":"Reporter assays, Co-IP of MafA-NeuroD1-HNF1β, ChIP-seq re-analysis, and binding-site mutagenesis","pmids":["34223824"],"confidence":"Medium","gaps":["Direct binary interactions within the trimeric complex not fully resolved","Single-lab study"]},{"year":2022,"claim":"Established HNF1B as sufficient (with cofactors) to specify renal tubular fate in reprogramming, and showed the R295C patient mutation selectively rewires specific target sets rather than globally reducing activity.","evidence":"Fibroblast-to-iREC reprogramming, Xenopus ectodermal organoids, WT vs R295C RNA-seq, and CRISPR knockdown in Xenopus","pmids":["36522156"],"confidence":"High","gaps":["Mechanism by which R295C selects target subsets unknown","Cofactor requirements for reprogramming not defined"]},{"year":2022,"claim":"Demonstrated that a MODY3 HNF1α truncation acts through physical interaction with HNF1B to impair pancreatic differentiation, and that restoring HNF1B function rescues progenitor and β-cell formation.","evidence":"hiPSC 3D organoids, CRISPR engineering, Co-IP, and HNF1B-overexpression rescue with flow cytometry","pmids":["35235779"],"confidence":"High","gaps":["Structural basis of the inhibitory interaction not defined","Extent of rescue in vivo not tested"]},{"year":2023,"claim":"Established HNF1B as causally required for uterine (Mullerian duct) development, providing a mechanism for MRKH type II syndrome.","evidence":"Mullerian-duct-specific conditional KO with single-cell RNA-seq and patient material analysis","pmids":["36282544"],"confidence":"High","gaps":["Direct HNF1B targets in Mullerian epithelium not validated by ChIP","Genetic basis in MRKH patients not fully resolved"]},{"year":null,"claim":"How HNF1B mutations selectively rewire distinct target-gene subsets across tissues, and what tissue-specific cofactors dictate its activator-versus-repressor switch, remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No unified model linking specific mutations to organ-specific phenotypes","Tissue-specific cofactor codes governing activation vs repression not defined","Structural basis of dimerization-dependent target selection unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,11,18,27]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,11,29]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[11,20]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[14,18,25,29]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,11,18,27]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[5,6,13,21,23,26]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[11,14,22,29,34]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[12,16,18,26]}],"complexes":[],"partners":["HNF1A","CBP","PCAF","CREB","E4F1","ZFP36L1","RBBP7","NEUROD1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P35680","full_name":"Hepatocyte nuclear factor 1-beta","aliases":["Homeoprotein LFB3","Transcription factor 2","TCF-2","Variant hepatic nuclear factor 1","vHNF1"],"length_aa":557,"mass_kda":61.3,"function":"Transcription factor that binds to the inverted palindrome 5'-GTTAATNATTAAC-3' (PubMed:17924661, PubMed:7900999). Binds to the FPC element in the cAMP regulatory unit of the PLAU gene (By similarity). Transcriptional activity is increased by coactivator PCBD1 (PubMed:24204001)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P35680/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HNF1B","classification":"Not Classified","n_dependent_lines":149,"n_total_lines":1208,"dependency_fraction":0.12334437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HNF1B","total_profiled":1310},"omim":[{"mim_id":"618610","title":"HOMEOBOX-CONTAINING PROTEIN 1; HMBOX1","url":"https://www.omim.org/entry/618610"},{"mim_id":"618500","title":"HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12","url":"https://www.omim.org/entry/618500"},{"mim_id":"616511","title":"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14; MODY14","url":"https://www.omim.org/entry/616511"},{"mim_id":"616090","title":"MICRO RNA 802; MIR802","url":"https://www.omim.org/entry/616090"},{"mim_id":"614527","title":"CHROMOSOME 17q12 DELETION SYNDROME","url":"https://www.omim.org/entry/614527"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"kidney","ntpm":67.4},{"tissue":"pancreas","ntpm":33.1}],"url":"https://www.proteinatlas.org/search/HNF1B"},"hgnc":{"alias_symbol":["LFB3","VHNF1","HNF1beta","MODY5","HNF1β"],"prev_symbol":["TCF2"]},"alphafold":{"accession":"P35680","domains":[{"cath_id":"1.10.260.40","chopping":"116-184","consensus_level":"high","plddt":95.8928,"start":116,"end":184},{"cath_id":"1.10.10.60","chopping":"239-318","consensus_level":"high","plddt":94.6004,"start":239,"end":318}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P35680","model_url":"https://alphafold.ebi.ac.uk/files/AF-P35680-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P35680-F1-predicted_aligned_error_v6.png","plddt_mean":60.72},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HNF1B","jax_strain_url":"https://www.jax.org/strain/search?query=HNF1B"},"sequence":{"accession":"P35680","fasta_url":"https://rest.uniprot.org/uniprotkb/P35680.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P35680/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P35680"}},"corpus_meta":[{"pmid":"1673926","id":"PMC_1673926","title":"vHNF1 is a homeoprotein that activates transcription and forms heterodimers with HNF1.","date":"1991","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/1673926","citation_count":276,"is_preprint":false},{"pmid":"11934849","id":"PMC_11934849","title":"Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1beta.","date":"2002","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11934849","citation_count":276,"is_preprint":false},{"pmid":"25536396","id":"PMC_25536396","title":"HNF1B-associated renal and extra-renal disease-an expanding clinical spectrum.","date":"2014","source":"Nature reviews. Nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/25536396","citation_count":253,"is_preprint":false},{"pmid":"15668393","id":"PMC_15668393","title":"Lack of TCF2/vHNF1 in mice leads to pancreas agenesis.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15668393","citation_count":200,"is_preprint":false},{"pmid":"10518495","id":"PMC_10518495","title":"Essential role for the homeoprotein vHNF1/HNF1beta in visceral endoderm differentiation.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10518495","citation_count":195,"is_preprint":false},{"pmid":"28219405","id":"PMC_28219405","title":"TTBK2 circular RNA promotes glioma malignancy by regulating miR-217/HNF1β/Derlin-1 pathway.","date":"2017","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/28219405","citation_count":189,"is_preprint":false},{"pmid":"19389850","id":"PMC_19389850","title":"HNF1B mutations associate with hypomagnesemia and renal magnesium wasting.","date":"2009","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/19389850","citation_count":187,"is_preprint":false},{"pmid":"10559500","id":"PMC_10559500","title":"Expression of the vHNF1/HNF1beta homeoprotein gene during mouse organogenesis.","date":"1999","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/10559500","citation_count":182,"is_preprint":false},{"pmid":"1673925","id":"PMC_1673925","title":"LFB3, a heterodimer-forming homeoprotein of the LFB1 family, is expressed in specialized epithelia.","date":"1991","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/1673925","citation_count":181,"is_preprint":false},{"pmid":"11731484","id":"PMC_11731484","title":"vhnf1, the MODY5 and familial GCKD-associated gene, regulates regional specification of the zebrafish gut, pronephros, and hindbrain.","date":"2001","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/11731484","citation_count":172,"is_preprint":false},{"pmid":"16258507","id":"PMC_16258507","title":"Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary.","date":"2006","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/16258507","citation_count":170,"is_preprint":false},{"pmid":"1363228","id":"PMC_1363228","title":"Expression patterns of vHNF1 and HNF1 homeoproteins in early postimplantation embryos suggest distinct and sequential developmental roles.","date":"1992","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/1363228","citation_count":151,"is_preprint":false},{"pmid":"1350532","id":"PMC_1350532","title":"LFB1 and LFB3 homeoproteins are sequentially expressed during kidney development.","date":"1992","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/1350532","citation_count":131,"is_preprint":false},{"pmid":"14570708","id":"PMC_14570708","title":"Hnf6 and Tcf2 (MODY5) are linked in a gene network operating in a precursor cell domain of the embryonic pancreas.","date":"2003","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14570708","citation_count":123,"is_preprint":false},{"pmid":"16801329","id":"PMC_16801329","title":"Severe pancreas hypoplasia and multicystic renal dysplasia in two human fetuses carrying novel HNF1beta/MODY5 mutations.","date":"2006","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16801329","citation_count":118,"is_preprint":false},{"pmid":"26160100","id":"PMC_26160100","title":"HNF1B-associated clinical phenotypes: the kidney and beyond.","date":"2015","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/26160100","citation_count":113,"is_preprint":false},{"pmid":"24897035","id":"PMC_24897035","title":"The HNF1B score is a simple tool to select patients for HNF1B gene analysis.","date":"2014","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/24897035","citation_count":106,"is_preprint":false},{"pmid":"25715395","id":"PMC_25715395","title":"Hnf1b controls pancreas morphogenesis and the generation of Ngn3+ endocrine progenitors.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25715395","citation_count":103,"is_preprint":false},{"pmid":"15342476","id":"PMC_15342476","title":"vhnf1 integrates global RA patterning and local FGF signals to direct posterior hindbrain development in zebrafish.","date":"2004","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15342476","citation_count":95,"is_preprint":false},{"pmid":"16297991","id":"PMC_16297991","title":"Identification of target genes of the transcription factor HNF1beta and HNF1alpha in a human embryonic kidney cell line.","date":"2005","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/16297991","citation_count":94,"is_preprint":false},{"pmid":"1685890","id":"PMC_1685890","title":"vHNF1 is expressed in epithelial cells of distinct embryonic origin during development and precedes HNF1 expression.","date":"1991","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/1685890","citation_count":93,"is_preprint":false},{"pmid":"18644064","id":"PMC_18644064","title":"Lack of pancreatic body and tail in HNF1B mutation carriers.","date":"2008","source":"Diabetic medicine : a journal of the British Diabetic Association","url":"https://pubmed.ncbi.nlm.nih.gov/18644064","citation_count":90,"is_preprint":false},{"pmid":"17923767","id":"PMC_17923767","title":"Distinct roles of HNF1beta, HNF1alpha, and HNF4alpha in regulating pancreas development, beta-cell function and growth.","date":"2007","source":"Endocrine development","url":"https://pubmed.ncbi.nlm.nih.gov/17923767","citation_count":88,"is_preprint":false},{"pmid":"15509593","id":"PMC_15509593","title":"HNF1beta/TCF2 mutations impair transactivation potential through altered co-regulator recruitment.","date":"2004","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15509593","citation_count":88,"is_preprint":false},{"pmid":"16221171","id":"PMC_16221171","title":"Roles of HNF-1beta in kidney development and congenital cystic diseases.","date":"2005","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/16221171","citation_count":86,"is_preprint":false},{"pmid":"20040500","id":"PMC_20040500","title":"vHNF1 functions in distinct regulatory circuits to control ureteric bud branching and early nephrogenesis.","date":"2010","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20040500","citation_count":84,"is_preprint":false},{"pmid":"19924231","id":"PMC_19924231","title":"Species-specific differences in the expression of the HNF1A, HNF1B and HNF4A genes.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19924231","citation_count":75,"is_preprint":false},{"pmid":"16380477","id":"PMC_16380477","title":"A vHNF1/TCF2-HNF6 cascade regulates the transcription factor network that controls generation of pancreatic precursor cells.","date":"2006","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/16380477","citation_count":74,"is_preprint":false},{"pmid":"12835397","id":"PMC_12835397","title":"vhnf1 and Fgf signals synergize to specify rhombomere identity in the zebrafish hindbrain.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12835397","citation_count":73,"is_preprint":false},{"pmid":"29961928","id":"PMC_29961928","title":"New insights into the role of HNF-1β in kidney (patho)physiology.","date":"2018","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/29961928","citation_count":72,"is_preprint":false},{"pmid":"18635606","id":"PMC_18635606","title":"Crucial role of vHNF1 in vertebrate hepatic specification.","date":"2008","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18635606","citation_count":71,"is_preprint":false},{"pmid":"8622679","id":"PMC_8622679","title":"Positive regulation of the vHNF1 promoter by the orphan receptors COUP-TF1/Ear3 and COUP-TFII/Arp1.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8622679","citation_count":71,"is_preprint":false},{"pmid":"26876668","id":"PMC_26876668","title":"Early Developmental Perturbations in a Human Stem Cell Model of MODY5/HNF1B Pancreatic Hypoplasia.","date":"2016","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26876668","citation_count":63,"is_preprint":false},{"pmid":"12874457","id":"PMC_12874457","title":"Distinct molecular and morphogenetic properties of mutations in the human HNF1beta gene that lead to defective kidney development.","date":"2003","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/12874457","citation_count":63,"is_preprint":false},{"pmid":"27234567","id":"PMC_27234567","title":"Chromosome 17q12 microdeletions but not intragenic HNF1B mutations link developmental kidney disease and psychiatric disorder.","date":"2016","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/27234567","citation_count":62,"is_preprint":false},{"pmid":"18077349","id":"PMC_18077349","title":"Mutations of HNF-1beta inhibit epithelial morphogenesis through dysregulation of SOCS-3.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18077349","citation_count":58,"is_preprint":false},{"pmid":"30032214","id":"PMC_30032214","title":"17q12 Deletion Syndrome as a Rare Cause for Diabetes Mellitus Type MODY5.","date":"2018","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/30032214","citation_count":52,"is_preprint":false},{"pmid":"29158444","id":"PMC_29158444","title":"HNF1B controls epithelial organization and cell polarity during ureteric bud branching and collecting duct morphogenesis.","date":"2017","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/29158444","citation_count":50,"is_preprint":false},{"pmid":"30097458","id":"PMC_30097458","title":"Mechanism of Fibrosis in HNF1B-Related Autosomal Dominant Tubulointerstitial Kidney Disease.","date":"2018","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/30097458","citation_count":49,"is_preprint":false},{"pmid":"7524626","id":"PMC_7524626","title":"Cloning and developmental expression of LFB3/HNF1 beta transcription factor in Xenopus laevis.","date":"1994","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/7524626","citation_count":48,"is_preprint":false},{"pmid":"26520442","id":"PMC_26520442","title":"HNF1β drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC).","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26520442","citation_count":47,"is_preprint":false},{"pmid":"15520459","id":"PMC_15520459","title":"Pattern of genes influenced by conditional expression of the transcription factors HNF6, HNF4alpha and HNF1beta in a pancreatic beta-cell line.","date":"2004","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/15520459","citation_count":46,"is_preprint":false},{"pmid":"36426859","id":"PMC_36426859","title":"Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients.","date":"2022","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/36426859","citation_count":45,"is_preprint":false},{"pmid":"29735694","id":"PMC_29735694","title":"Genomic integration of ERRγ-HNF1β regulates renal bioenergetics and prevents chronic kidney disease.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29735694","citation_count":43,"is_preprint":false},{"pmid":"19998368","id":"PMC_19998368","title":"HNF1B and JAZF1 genes, diabetes, and prostate cancer risk.","date":"2010","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/19998368","citation_count":41,"is_preprint":false},{"pmid":"24040285","id":"PMC_24040285","title":"Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24040285","citation_count":41,"is_preprint":false},{"pmid":"31636385","id":"PMC_31636385","title":"HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/31636385","citation_count":41,"is_preprint":false},{"pmid":"26375553","id":"PMC_26375553","title":"Ovarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reduction.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26375553","citation_count":40,"is_preprint":false},{"pmid":"22511595","id":"PMC_22511595","title":"Hnf1b and Pax2 cooperate to control different pathways in kidney and ureter morphogenesis.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22511595","citation_count":38,"is_preprint":false},{"pmid":"31131422","id":"PMC_31131422","title":"Clinical characteristics of HNF1B-related disorders in a Japanese population.","date":"2019","source":"Clinical and experimental nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/31131422","citation_count":38,"is_preprint":false},{"pmid":"22114815","id":"PMC_22114815","title":"Genetic basis of prune belly syndrome: screening for HNF1β gene.","date":"2011","source":"The Journal of urology","url":"https://pubmed.ncbi.nlm.nih.gov/22114815","citation_count":38,"is_preprint":false},{"pmid":"26318292","id":"PMC_26318292","title":"Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26318292","citation_count":37,"is_preprint":false},{"pmid":"30535056","id":"PMC_30535056","title":"Frequency and Characteristics of MODY 1 (HNF4A Mutation) and MODY 5 (HNF1B Mutation): Analysis From the DPV Database.","date":"2019","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/30535056","citation_count":37,"is_preprint":false},{"pmid":"25741167","id":"PMC_25741167","title":"Hepatic phenotypes of HNF1B gene mutations: a case of neonatal cholestasis requiring portoenterostomy and literature review.","date":"2015","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/25741167","citation_count":35,"is_preprint":false},{"pmid":"27732966","id":"PMC_27732966","title":"HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27732966","citation_count":35,"is_preprint":false},{"pmid":"29478894","id":"PMC_29478894","title":"Heterogeneity of SOX9 and HNF1β in Pancreatic Ducts Is Dynamic.","date":"2018","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29478894","citation_count":33,"is_preprint":false},{"pmid":"17996499","id":"PMC_17996499","title":"Expression of HNF-4alpha (MODY1), HNF-1beta (MODY5), and HNF-1alpha (MODY3) proteins in the developing mouse pancreas.","date":"2007","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/17996499","citation_count":32,"is_preprint":false},{"pmid":"36672242","id":"PMC_36672242","title":"The Landscape of HNF1B Deficiency: A Syndrome Not Yet Fully Explored.","date":"2023","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36672242","citation_count":29,"is_preprint":false},{"pmid":"35235779","id":"PMC_35235779","title":"An HNF1α truncation associated with maturity-onset diabetes of the young impairs pancreatic progenitor differentiation by antagonizing HNF1β function.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35235779","citation_count":29,"is_preprint":false},{"pmid":"16110512","id":"PMC_16110512","title":"vHnf1 regulates specification of caudal rhombomere identity in the chick hindbrain.","date":"2005","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/16110512","citation_count":26,"is_preprint":false},{"pmid":"17669392","id":"PMC_17669392","title":"Direct regulation of vHnf1 by retinoic acid signaling and MAF-related factors in the neural tube.","date":"2007","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17669392","citation_count":24,"is_preprint":false},{"pmid":"17476318","id":"PMC_17476318","title":"Mutational analyses of UPIIIA, SHH, EFNB2 and HNF1beta in persistent cloaca and associated kidney malformations.","date":"2007","source":"Journal of pediatric urology","url":"https://pubmed.ncbi.nlm.nih.gov/17476318","citation_count":24,"is_preprint":false},{"pmid":"25739652","id":"PMC_25739652","title":"HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies.","date":"2015","source":"Cancer cytopathology","url":"https://pubmed.ncbi.nlm.nih.gov/25739652","citation_count":24,"is_preprint":false},{"pmid":"16274963","id":"PMC_16274963","title":"The vHNF1 homeodomain protein establishes early rhombomere identity by direct regulation of Kreisler expression.","date":"2005","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/16274963","citation_count":23,"is_preprint":false},{"pmid":"18418350","id":"PMC_18418350","title":"Transcription factor HNF1beta and novel partners affect nephrogenesis.","date":"2008","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/18418350","citation_count":22,"is_preprint":false},{"pmid":"28807937","id":"PMC_28807937","title":"HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas.","date":"2017","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/28807937","citation_count":22,"is_preprint":false},{"pmid":"17217944","id":"PMC_17217944","title":"Vhnf1 acts downstream of Bmp, Fgf, and RA signals to regulate endocrine beta cell development in zebrafish.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17217944","citation_count":21,"is_preprint":false},{"pmid":"36282544","id":"PMC_36282544","title":"Functional genomics analysis identifies loss of HNF1B function as a cause of Mayer-Rokitansky-Küster-Hauser syndrome.","date":"2023","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36282544","citation_count":21,"is_preprint":false},{"pmid":"32708349","id":"PMC_32708349","title":"Genotype and Phenotype Analyses in Pediatric Patients with HNF1B Mutations.","date":"2020","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32708349","citation_count":21,"is_preprint":false},{"pmid":"26685938","id":"PMC_26685938","title":"Expression, Epigenetic and Genetic Changes of HNF1B in Endometrial Lesions.","date":"2015","source":"Pathology oncology research : POR","url":"https://pubmed.ncbi.nlm.nih.gov/26685938","citation_count":20,"is_preprint":false},{"pmid":"34953915","id":"PMC_34953915","title":"MNX1-HNF1B Axis Is Indispensable for Intraductal Papillary Mucinous Neoplasm Lineages.","date":"2021","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/34953915","citation_count":20,"is_preprint":false},{"pmid":"28324003","id":"PMC_28324003","title":"Biliary Anomalies in Patients With HNF1B Diabetes.","date":"2017","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/28324003","citation_count":20,"is_preprint":false},{"pmid":"17137573","id":"PMC_17137573","title":"Role of the hindbrain in patterning the otic vesicle: a study of the zebrafish vhnf1 mutant.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17137573","citation_count":20,"is_preprint":false},{"pmid":"36443337","id":"PMC_36443337","title":"Extensive germline-somatic interplay contributes to prostate cancer progression through HNF1B co-option of TMPRSS2-ERG.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36443337","citation_count":20,"is_preprint":false},{"pmid":"31361605","id":"PMC_31361605","title":"Napsin-A and AMACR are Superior to HNF-1β in Distinguishing Between Mesonephric Carcinomas and Clear Cell Carcinomas of the Gynecologic Tract.","date":"2020","source":"Applied immunohistochemistry & molecular morphology : AIMM","url":"https://pubmed.ncbi.nlm.nih.gov/31361605","citation_count":20,"is_preprint":false},{"pmid":"30021660","id":"PMC_30021660","title":"Genome-wide methylomic analysis in individuals with HNF1B intragenic mutation and 17q12 microdeletion.","date":"2018","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/30021660","citation_count":19,"is_preprint":false},{"pmid":"9671480","id":"PMC_9671480","title":"Role of tissue-specific transcription factor LFB3 in a cyclic AMP-responsive enhancer of the urokinase-type plasminogen activator gene in LLC-PK1 cells.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9671480","citation_count":19,"is_preprint":false},{"pmid":"34067626","id":"PMC_34067626","title":"Acquired Evolution of Mitochondrial Metabolism Regulated by HNF1B in Ovarian Clear Cell Carcinoma.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34067626","citation_count":19,"is_preprint":false},{"pmid":"27059371","id":"PMC_27059371","title":"Differential regulation of serum microRNA expression by HNF1β and HNF1α transcription factors.","date":"2016","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/27059371","citation_count":18,"is_preprint":false},{"pmid":"33174391","id":"PMC_33174391","title":"HNF1B inhibits cell proliferation via repression of SMAD6 expression in prostate cancer.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33174391","citation_count":18,"is_preprint":false},{"pmid":"29561186","id":"PMC_29561186","title":"Transcription factor HNF1β regulates expression of the calcium-sensing receptor in the thick ascending limb of the kidney.","date":"2018","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29561186","citation_count":18,"is_preprint":false},{"pmid":"24332637","id":"PMC_24332637","title":"Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.","date":"2013","source":"Urologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24332637","citation_count":18,"is_preprint":false},{"pmid":"2081590","id":"PMC_2081590","title":"Mapping of the gene TCF2 coding for the transcription factor LFB3 to human chromosome 17 by polymerase chain reaction.","date":"1990","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/2081590","citation_count":18,"is_preprint":false},{"pmid":"36522156","id":"PMC_36522156","title":"HNF1B Alters an Evolutionarily Conserved Nephrogenic Program of Target Genes.","date":"2022","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/36522156","citation_count":17,"is_preprint":false},{"pmid":"7665606","id":"PMC_7665606","title":"Role of LFB3 in cell-specific cAMP induction of the urokinase-type plasminogen activator gene.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7665606","citation_count":16,"is_preprint":false},{"pmid":"25705165","id":"PMC_25705165","title":"Identification and Functional Characterization of P159L Mutation in HNF1B in a Family with Maturity-Onset Diabetes of the Young 5 (MODY5).","date":"2014","source":"Genomics & informatics","url":"https://pubmed.ncbi.nlm.nih.gov/25705165","citation_count":16,"is_preprint":false},{"pmid":"27286685","id":"PMC_27286685","title":"Hyperechogenic kidneys and polyhydramnios associated with HNF1B gene mutation.","date":"2016","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/27286685","citation_count":16,"is_preprint":false},{"pmid":"15302404","id":"PMC_15302404","title":"Two distinct teleost hepatocyte nuclear factor 1 genes, hnf1alpha/tcf1 and hnf1beta/tcf2, abundantly expressed in liver, pancreas, gut and kidney of zebrafish.","date":"2004","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/15302404","citation_count":16,"is_preprint":false},{"pmid":"24190171","id":"PMC_24190171","title":"Hnf1beta and nephron segmentation.","date":"2013","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/24190171","citation_count":15,"is_preprint":false},{"pmid":"39408938","id":"PMC_39408938","title":"HNF1B Transcription Factor: Key Regulator in Renal Physiology and Pathogenesis.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39408938","citation_count":15,"is_preprint":false},{"pmid":"18945197","id":"PMC_18945197","title":"hnf1b genes in zebrafish hindbrain development.","date":"2008","source":"Zebrafish","url":"https://pubmed.ncbi.nlm.nih.gov/18945197","citation_count":15,"is_preprint":false},{"pmid":"30791938","id":"PMC_30791938","title":"Not only Alagille syndrome. Syndromic paucity of interlobular bile ducts secondary to HNF1β deficiency: a case report and literature review.","date":"2019","source":"Italian journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/30791938","citation_count":15,"is_preprint":false},{"pmid":"39156164","id":"PMC_39156164","title":"Renal and Extrarenal Phenotypes in Patients With HNF1B Variants and Chromosome 17q12 Microdeletions.","date":"2024","source":"Kidney international reports","url":"https://pubmed.ncbi.nlm.nih.gov/39156164","citation_count":13,"is_preprint":false},{"pmid":"34223824","id":"PMC_34223824","title":"MafA, NeuroD1, and HNF1β synergistically activate the Slc2a2 (Glut2) gene in β-cells.","date":"2021","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/34223824","citation_count":13,"is_preprint":false},{"pmid":"27107701","id":"PMC_27107701","title":"Forced expression of Hnf1b/Foxa3 promotes hepatic fate of embryonic stem cells.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/27107701","citation_count":13,"is_preprint":false},{"pmid":"25884453","id":"PMC_25884453","title":"Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases.","date":"2015","source":"Diagnostic pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25884453","citation_count":13,"is_preprint":false},{"pmid":"38692196","id":"PMC_38692196","title":"Exosomal circ50547 as a potential marker and promotor of gastric cancer progression via miR-217/HNF1B axis.","date":"2024","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/38692196","citation_count":13,"is_preprint":false},{"pmid":"15660195","id":"PMC_15660195","title":"Scanning for MODY5 gene mutations in Chinese early onset or multiple affected diabetes pedigrees.","date":"2004","source":"Acta diabetologica","url":"https://pubmed.ncbi.nlm.nih.gov/15660195","citation_count":12,"is_preprint":false},{"pmid":"9523012","id":"PMC_9523012","title":"A set of polyclonal and monoclonal antibodies reveals major differences in post-translational modification of the rat HNF1 and vHNF1 homeoproteins.","date":"1997","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/9523012","citation_count":12,"is_preprint":false},{"pmid":"22641569","id":"PMC_22641569","title":"HNF-1β mutation affects PKD2 and SOCS3 expression causing renal cysts and diabetes in MODY5 kindred.","date":"2013","source":"Journal of nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/22641569","citation_count":11,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52876,"output_tokens":9644,"usd":0.151644,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19990,"output_tokens":8562,"usd":0.157,"stage2_stop_reason":"end_turn"},"total_usd":0.308644,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1991,\n      \"finding\": \"HNF1B (vHNF1/LFB3) forms heterodimers with HNF1 (HNF1α) both in vitro and in nuclear extracts of kidney, liver, and cell lines; it also transactivates the albumin promoter in transfection experiments, establishing it as a transcriptional activator.\",\n      \"method\": \"In vitro heterodimerization assay, nuclear extract biochemical characterization, transfection/transactivation assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro reconstitution of heterodimerization plus functional transactivation assay, replicated independently by two labs (PMID:1673926 and PMID:1673925) in the same year\",\n      \"pmids\": [\"1673926\", \"1673925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"LFB3/HNF1B binds DNA as a dimer and forms heterodimers with LFB1 (HNF1α) both in vitro and in vivo; it acts as a transcriptional activator.\",\n      \"method\": \"DNA binding assays, in vitro and in vivo heterodimerization, transcriptional activation assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — independent replication of heterodimerization and transactivation by a second lab, consistent with PMID:1673926\",\n      \"pmids\": [\"1673925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The vHNF1 promoter is transactivated by orphan receptors COUP-TF1/Ear3 and COUP-TFII/Arp1 via an indirect mechanism involving an interaction between COUP-TFI/Ear3 and octamer-binding proteins; a proximal octamer site (not the DR-1 site) is required for this transactivation. HNF4 has virtually no effect on the vHNF1 promoter, unlike the HNF1α promoter.\",\n      \"method\": \"Promoter deletion analysis, DNA-protein interaction (gel shift/footprinting), transfection/transactivation assays, mammalian two-hybrid interaction assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal methods (footprinting, reporter assays, protein interaction) in a single rigorous study\",\n      \"pmids\": [\"8622679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"HNF1B (vHNF1) protein exists in vivo as two isoforms of ~65 and ~68 kDa, revealing differential post-translational modification compared to HNF1α, which appears as a heterogeneous mixture of 92–98 kDa polypeptides (higher than predicted from sequence).\",\n      \"method\": \"Polyclonal and monoclonal antibody characterization of liver and kidney extracts (western blot/immunoprecipitation)\",\n      \"journal\": \"Biochimie\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — antibody-based detection of isoforms in tissue extracts; single lab but multiple antibody reagents confirming differential modification\",\n      \"pmids\": [\"9523012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"LFB3/HNF1B binds to the C domain of a cAMP-responsive enhancer of the urokinase-type plasminogen activator gene in LLC-PK1 kidney cells and cooperates with CREB/ATF1 proteins to mediate cAMP induction; the region of LFB3 between amino acids 400–450 mediates interaction with CREB/ATF1, and deletion of this region abolishes cAMP induction but not basal transactivation on the albumin promoter.\",\n      \"method\": \"Mutation analysis, transfection assay, mammalian two-hybrid system, domain deletion analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — functional domain mapping by deletion mutagenesis combined with protein–protein interaction assay and reporter assay, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"9671480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Homozygous inactivation of vHNF1/HNF1B in mice results in embryonic lethality by day 7.5 with disorganized visceral endoderm; vHNF1 expression is essential for visceral endoderm differentiation and is part of a genetic network directing HNF4 and downstream endodermal gene expression. The lethal phenotype is cell-autonomous to the visceral endoderm.\",\n      \"method\": \"Homologous recombination knockout mouse, ES cell differentiation, tetraploid morula aggregation (complementation), in situ hybridization of marker genes\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined cellular phenotype, tetraploid complementation to establish cell autonomy, multiple marker genes analyzed\",\n      \"pmids\": [\"10518495\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"In zebrafish, vhnf1 loss-of-function causes kidney cysts, underdevelopment of pancreas and liver, and otic vesicle defects by disrupting regional patterning; vhnf1 directly regulates expression of pdx1 and shh in gut endoderm, pax2 and wt1 in pronephric primordia, and valentino (val) in hindbrain. Overexpression of vhnf1 expands the val expression domain, demonstrating direct epistatic control.\",\n      \"method\": \"Insertional mutagenesis screen (zebrafish), mRNA overexpression, in situ hybridization of target genes, genetic epistasis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function and gain-of-function with defined molecular targets across multiple organs, with overexpression rescue\",\n      \"pmids\": [\"11731484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Hepatocyte/bile-duct-specific deletion of HNF1B in mice causes failure of intrahepatic bile duct morphogenesis, gallbladder abnormalities, and loss of hepatocyte-specific target genes involved in bile acid sensing and fatty acid oxidation, establishing an essential role of HNF1B in bile system morphogenesis and hepatocyte metabolic gene regulation.\",\n      \"method\": \"Cre/loxP conditional knockout (hepatocyte/bile duct-specific), histology, gene expression analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — tissue-specific conditional KO with defined morphological and molecular phenotype, identification of hepatocyte-specific target genes\",\n      \"pmids\": [\"11934849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"vHNF1/HNF1B directly binds the Kreisler (MafB/val) regulatory element S5 in rhombomere 5/6, and this binding site is essential (but not sufficient) for r5/r6-specific Kreisler expression in early embryos; vHNF1 acts with additional transcription factors to initiate Kreisler expression, establishing direct transcriptional control of hindbrain segmentation.\",\n      \"method\": \"Transgenic reporter (S5 regulatory element), site-directed mutagenesis of vHNF1-binding site, evolutionary sequence conservation analysis\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic enhancer assay with mutagenesis of binding site, single lab\",\n      \"pmids\": [\"16274963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"vHNF1 (zebrafish) promotes r5+r6 identity through obligate synergy with FGF signals to activate valentino and krox20, and independently represses hoxb1a expression; these are two functionally separable activities of vhnf1 in subdividing the caudal hindbrain.\",\n      \"method\": \"Zebrafish genetic analysis, FGF pathway inhibition, in situ hybridization, epistasis experiments\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic dissection of two independent molecular activities with pathway inhibition, replicated in related studies (PMID:15342476)\",\n      \"pmids\": [\"12835397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"In embryonic pancreas, Hnf1beta+ cells (ductal cells) are the immediate precursors of Ngn3+ endocrine precursor cells; Hnf1beta expression is markedly reduced in early pancreatic epithelium of Hnf6-deficient mice (in which Ngn3+ cell formation is defective), placing Hnf1b downstream of Hnf6 in a genetic hierarchy controlling endocrine cell generation.\",\n      \"method\": \"Immunohistochemistry, genetic epistasis (Hnf6 KO mice), co-localization/lineage analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis in KO mice combined with cellular co-localization; single lab\",\n      \"pmids\": [\"14570708\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"HNF1B/TCF2 mutations causing MODY5 impair transactivation through two distinct mechanisms: (1) loss of DNA-binding capacity, or (2) retention of DNA binding but loss of association with histone acetyltransferases CBP and PCAF. Wild-type HNF1β transactivation depends on synergistic action of CBP and PCAF; truncation mutations causing defective nuclear localization show weak dominant-negative activity; the C-terminal QSP-rich domain is required for full transactivation.\",\n      \"method\": \"In vitro mutagenesis, transfection/reporter assay, co-immunoprecipitation with CBP/PCAF, nuclear localization studies, HDAC inhibitor (TSA) treatment\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (mutagenesis, Co-IP, reporter assay, drug treatment) characterizing multiple disease mutations, single lab with rigorous mechanistic follow-up\",\n      \"pmids\": [\"15509593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"vHNF1/HNF1B integrates retinoic acid (RA) signals and FGF signals in hindbrain patterning: RA induces val expression via activation of vhnf1; FGF signals from r4 (through MAPK pathway) then cooperate with Vhnf1 to activate val and specify r5/r6. vhnf1 acts largely independently of val to repress r4 identity in the posterior hindbrain.\",\n      \"method\": \"Zebrafish genetic analysis, RA treatment, FGF pathway manipulation, MAPK pathway analysis, in situ hybridization, epistasis experiments\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — pathway dissection using genetic and pharmacological approaches with clear epistatic ordering, replicated across multiple hindbrain studies\",\n      \"pmids\": [\"15342476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Tcf2/vHNF1 is essential for early pancreas development; Tcf2-null mice (rescued from early lethality by tetraploid aggregation) exhibit pancreas agenesis by E13.5. The dorsal bud rudiment that forms transiently expresses Ipf1 and Hlxb9 but lacks Ptf1a and endocrine precursor cells. Tcf2 also controls regional specification of gut (ectopic Shh, loss of Ihh/Ipf1 in posterior stomach/duodenum), establishing epistatic control of Ptf1a and gut patterning genes.\",\n      \"method\": \"Tetraploid embryo aggregation rescue of null embryos, in situ hybridization of key transcription factors, immunohistochemistry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional rescue of early-lethal KO by tetraploid aggregation, multiple molecular targets validated by in situ hybridization\",\n      \"pmids\": [\"15668393\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HNF1B directly regulates the Pkhd1 promoter in kidney; HNF1B mutant mice show decreased Pkhd1 expression and develop renal cysts, linking MODY5/HNF1B-associated cystic kidney disease to downregulation of the ARPKD gene PKHD1.\",\n      \"method\": \"Transgenic mice with kidney-specific mutant HNF1B, Cre/loxP kidney-specific deletion, promoter binding/ChIP for Pkhd1, gene expression analysis\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct promoter regulation shown in two independent mouse models (transgenic mutant + conditional KO) with molecular validation\",\n      \"pmids\": [\"16221171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HNF1β target genes identified in HEK293 kidney cells include DPP4, ACE2, and osteopontin (SPP1), which contain functional HNF1 binding sites in their promoters and are directly regulated; nine of 25 identified target genes are deregulated in ovarian clear cell carcinoma.\",\n      \"method\": \"Conditional HNF1B expression system (Flp recombinase, tetracycline-inducible), oligonucleotide microarray, promoter analysis for HNF1 binding sites\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide expression profiling with conditional expression system and promoter binding site validation; single lab\",\n      \"pmids\": [\"16297991\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In zebrafish, Bmp signaling is required for vhnf1 expression in endoderm (Bmp pathway activation expands, Bmp pathway loss reduces vhnf1); Fgf signaling regulates pancreas development through the vhnf1 pathway; vhnf1 acts downstream of RA, Bmp, and Fgf signals to regulate endocrine beta cell development. RA cannot rescue vhnf1 mutant insulin defects, but vhnf1 overexpression restores insulin expression blocked by RA receptor inhibition.\",\n      \"method\": \"Morpholino knockdown (chordin, alk8), FGF pathway inhibition, RA receptor inhibitor, mRNA overexpression rescue, in situ hybridization, genetic epistasis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple pathway manipulations with epistasis ordering, rescue experiments; consistent with independent zebrafish hindbrain studies\",\n      \"pmids\": [\"17217944\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"vHNF1/TCF2 (acting upstream) activates HNF6 expression through a functional HNF1-binding site in an intronic enhancer of Hnf6; this establishes a vHNF1→HNF6→Pdx1 sequential cascade controlling generation of pancreatic precursor cells in the endoderm.\",\n      \"method\": \"In vitro protein-DNA interaction, endoderm electroporation reporter assay, transgenesis, gene inactivation, Hnf6 KO mice, Tcf2 KO mice\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct protein-DNA binding combined with multiple in vivo models (electroporation, transgenesis, KO) confirming vHNF1→HNF6 epistatic relationship\",\n      \"pmids\": [\"16380477\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HNF1β directly binds the SOCS3 promoter and represses SOCS3 transcription in kidney epithelial cells. In HNF1β knockout mice and cells expressing dominant-negative HNF1β, increased SOCS3 inhibits HGF-induced tubulogenesis by decreasing phosphorylation of ERK and STAT3. Knockdown of SOCS3 in dominant-negative HNF1β-expressing cells rescues tubulogenesis by restoring ERK and STAT3 phosphorylation.\",\n      \"method\": \"Genome-wide ChIP-chip (chromatin immunoprecipitation + microarray), mRNA microarray, HNF1β knockout mouse, dominant-negative HNF1β cell line, SOCS3 knockdown rescue, tubulogenesis assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — genome-wide ChIP identifies direct target, KO mouse validates in vivo, siRNA rescue with defined signaling readouts (ERK/STAT3 phosphorylation)\",\n      \"pmids\": [\"18077349\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"A conserved 800-bp enhancer in intron 4 of vHnf1 recapitulates its neural expression pattern in transgenic mice; functional analysis identifies two essential motif types: a retinoic acid response element and two half T-MARE sites, demonstrating direct integration of RA signaling and MAF-related factor inputs into vHnf1 expression. MAFB, itself regulated by vHNF1, acts as a positive modulator of vHnf1 in r5/r6 (feedback loop).\",\n      \"method\": \"Transgenic enhancer reporter mice, site-directed mutagenesis of RARE and T-MARE sites\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — transgenic reporter with mutagenesis of cis-regulatory elements, single lab but in vivo validation\",\n      \"pmids\": [\"17669392\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HNF1β interacts physically with five novel protein partners (including E4F1 and ZFP36L1) identified by bacterial two-hybrid screen using the N-terminal region of HNF1B, with four confirmed by GST pull-down. ZFP36L1, predominantly cytoplasmic, can reduce HNF1β transactivation in a luciferase reporter system. E4F1 co-localizes with HNF1β in the nucleus.\",\n      \"method\": \"Bacterial two-hybrid screen, GST pull-down confirmation, luciferase reporter assay, co-localization by immunofluorescence, Xenopus overexpression for phenotypic validation\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — bacterial two-hybrid + GST pull-down for interaction identification with functional reporter assay; single lab\",\n      \"pmids\": [\"18418350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"vHNF1 (HNF1B) is required cell-autonomously for hepatic specification; loss of vHnf1 in mouse ventral endoderm blocks thickening, expression of hepatic genes, and responsiveness to inductive FGF signals in vitro. In zebrafish, the same conserved role is confirmed, establishing vHNF1 as required for endoderm competence and hepatic specification.\",\n      \"method\": \"Tetraploid complementation (vHnf1 KO mouse), in vitro culture of mutant ventral endoderm with FGF, zebrafish knockdown, in situ hybridization of hepatic specification markers (albumin, transthyretin)\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — combined mouse (KO rescued by tetraploid aggregation) and zebrafish models with in vitro FGF responsiveness assay, multiple molecular markers\",\n      \"pmids\": [\"18635606\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HNF1B directly transactivates the FXYD2 promoter (shown by luciferase reporter assay), and HNF1B mutations associate with hypomagnesemia and renal magnesium wasting, establishing that HNF1B regulates FXYD2 transcription to control tubular Mg2+ handling.\",\n      \"method\": \"Luciferase reporter assay with HNF1 recognition site in FXYD2 promoter, clinical cohort analysis with plasma magnesium measurements\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct promoter transactivation assay with in silico identification of binding site; clinical phenotype supports mechanistic link; single lab\",\n      \"pmids\": [\"19389850\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"vHNF1 (HNF1B) controls early kidney development through two distinct regulatory circuits: (1) it regulates ureteric bud (UB) outgrowth and branching morphogenesis in a cell-autonomous manner; (2) it maintains nephric duct epithelium, controls Müllerian duct formation, and regulates early nephrogenesis. vHNF1 directly controls Wnt9b, which acts upstream of mesenchymal-epithelial transitions initiating nephrogenesis.\",\n      \"method\": \"Conditional (Cre/loxP) and mosaic inactivation of vHnf1 in mouse kidney, in situ hybridization and expression analysis of Wnt9b and other target genes, ChIP for direct target confirmation\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with mosaic analysis to establish cell autonomy, direct target (Wnt9b) validated by ChIP, multiple molecular targets identified\",\n      \"pmids\": [\"20040500\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Compound heterozygous inactivation of Hnf1b and Pax2 in mice produces severe CAKUT phenotypes beyond those of either single heterozygote, revealing Hnf1b as a modifier of Pax2 haploinsufficiency. Compound mutants show delayed nephron segmentation, increased apoptosis, reduced Lim1/Wnt4 expression, and perturbation of ureter smooth muscle differentiation with downregulation of Bmp4 and Tbx18, establishing cooperative roles in kidney and ureter morphogenesis.\",\n      \"method\": \"Compound heterozygous mouse genetics, in situ hybridization, expression analysis of molecular markers\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis via compound heterozygous mouse model with multiple molecular readouts; single lab\",\n      \"pmids\": [\"22511595\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Conditional inactivation of Hnf1b in mouse pancreas causes: (1) reduced pancreatic multipotent progenitor cell pool due to decreased proliferation and increased apoptosis; (2) cystic ducts with aberrant cell polarity and decreased expression of cystic disease genes; (3) loss/abnormal differentiation of acinar cells; and (4) absence of Ngn3+ endocrine precursors throughout embryogenesis. HNF1B directly occupies putative Ngn3 regulatory sequences in vivo. Glis3 is identified as a novel HNF1B downstream target controlling duct morphogenesis and endocrine development.\",\n      \"method\": \"Constitutive and inducible conditional Cre/loxP inactivation of Hnf1b at different developmental stages, ChIP (HNF1B occupancy at Ngn3 regulatory sequences), expression analysis, cell proliferation/apoptosis assays\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple conditional KO models at different developmental stages, direct ChIP for Ngn3 regulatory sequences, multiple orthogonal methods\",\n      \"pmids\": [\"25715395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Specific removal of Hnf1b from the ureteric bud causes defective cell-cell contacts, loss of apicobasal polarity, and decreased cell rearrangements during mitosis-associated cell dispersal, leading to severe epithelial disorganization, mispatterned ureteric tree, and cystogenesis. HNF1B acts both upstream and downstream of Ret signaling by directly regulating Gfra1 and Etv5.\",\n      \"method\": \"Ureteric bud-specific Cre/loxP conditional KO, high-resolution ex vivo live imaging with membranous fluorescent reporter, mRNA-seq, promoter/binding analysis for Gfra1/Etv5\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific conditional KO with live imaging revealing cellular mechanisms, mRNA-seq, and direct target gene identification\",\n      \"pmids\": [\"29158444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HNF1β directly represses Twist2 transcription in renal epithelial cells. Loss of HNF1β activates a Twist2-dependent transcriptional network including Snail1, Snail2, and Zeb2 (EMT transcription factors). HNF1β-deficient epithelial cells secrete high levels of TGF-β ligands that activate Smad transcription factors in renal interstitial cells, causing fibrosis through a cell-non-autonomous mechanism (not by direct epithelial-to-myofibroblast transdifferentiation, as shown by lineage tracing).\",\n      \"method\": \"HNF1β-deficient mIMCD3 cells, RNA-seq, ChIP (direct Twist2 repression), Twist2 knockdown rescue, cell lineage analysis in HNF1β mutant mice\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct ChIP demonstrating Twist2 repression, siRNA rescue of fibroblastic phenotype, lineage tracing to establish non-cell-autonomous mechanism, RNA-seq for pathway identification\",\n      \"pmids\": [\"30097458\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ERRγ and HNF1β cooperate to control renal reabsorption through convergent genomic binding; ERRγ directly regulates mitochondrial metabolism and cooperatively controls renal reabsorption via convergent binding with HNF1β. Deletion of ERRγ in renal epithelial cells phenocopies HNF1β loss-of-function, producing overlapping renal transcriptional signatures.\",\n      \"method\": \"Conditional renal epithelial ERRγ KO mouse, ChIP-seq showing co-occupancy, transcriptomic comparison to HNF1β mutant phenotype\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq demonstrating co-occupancy, KO mouse with phenotypic comparison; interaction with HNF1β not directly confirmed by Co-IP\",\n      \"pmids\": [\"29735694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HNF1β is a transcriptional activator of the calcium-sensing receptor (CaSR) gene in the thick ascending limb (TAL) of the kidney; a conserved HNF1β binding site in CaSR intron 2 mediates this activation. A DNA-binding-deficient HNF1β mutant (p.Lys156Glu) abolishes CaSR expression. Hnf1β knockdown in TAL cells reduces CaSR and Cldn14 expression and upregulates Cldn10b; kidney-specific HNF1β KO mice show 81% downregulation of Casr.\",\n      \"method\": \"HNF1β ChIP-seq (binding site identification), luciferase-promoter assay, DNA-binding mutant (p.Lys156Glu), Hnf1β siRNA knockdown in MKTAL cells, kidney-specific HNF1β KO mouse, qRT-PCR\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — ChIP-seq + reporter assay + binding-defective mutant + KO mouse, multiple orthogonal methods in single study\",\n      \"pmids\": [\"29561186\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HNF1B transcriptionally represses SLUG (SNAI2) expression through interaction with RBBP7/RbAP46, and this repression suppresses EMT. EZH2 directly binds the HNF1B locus and suppresses HNF1B expression in prostate cancer cells, establishing an EZH2→HNF1B→SLUG axis regulating EMT.\",\n      \"method\": \"ChIP-seq (HNF1B promoter binding by EZH2; HNF1B target gene binding), RNA-seq, Co-IP (HNF1B–RBBP7 interaction), luciferase reporter for SLUG, overexpression/knockdown cell assays, clinical correlation\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq plus Co-IP for RBBP7 interaction, with functional EMT assays; single lab\",\n      \"pmids\": [\"31636385\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MafA, NeuroD1, and HNF1β synergistically activate the Slc2a2 (Glut2) gene in β-cells through simultaneous binding to both the proximal promoter and a distal enhancer (ECR3') ~40 kb downstream. Co-immunoprecipitation suggests MafA, NeuroD1, and HNF1β physically interact with each other; simultaneous HNF1β binding to both regulatory elements is indispensable for transcriptional activation.\",\n      \"method\": \"Luciferase reporter assay, co-immunoprecipitation (MafA–NeuroD1–HNF1β complex), ChIP-seq data re-analysis, mutagenesis of binding sites\",\n      \"journal\": \"Journal of molecular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for protein interaction, reporter assays with binding site mutagenesis; single lab\",\n      \"pmids\": [\"34223824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"HNF1B is essential for reprogramming mouse fibroblasts to induced renal tubular epithelial cells (iRECs) and for inducing ectopic pronephric tissue in Xenopus ectodermal organoids. The patient mutation R295C retains overall reprogramming capacity but selectively alters expression of specific downstream target gene sets rather than globally reducing HNF1β transcriptional activity. Cross-species conserved HNF1B transcriptional targets are dysregulated in hnf1b CRISPR-depleted Xenopus embryos.\",\n      \"method\": \"Direct reprogramming of mouse fibroblasts, Xenopus ectodermal explant assay, bulk RNA-seq (wild-type vs. R295C mutant), CRISPR/Cas9 in Xenopus\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — two independent experimental systems (fibroblast reprogramming + Xenopus organoid), patient mutation functional characterization, CRISPR validation in vivo\",\n      \"pmids\": [\"36522156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The HNF1αp291fsinsC truncation (MODY3) interacts with HNF1β and inhibits its function in pancreatic progenitor differentiation; disrupting the HNF1α–HNF1β interaction partially rescues HNF1β-dependent transcription. HNF1β overexpression in the HNF1αp291fsinsC background increases PDX1+ progenitors and partially rescues β cell differentiation.\",\n      \"method\": \"hiPSC-derived 3D organoids, CRISPR/Cas9 engineering, Co-IP (HNF1αp291fsinsC–HNF1β interaction), HNF1β overexpression rescue, flow cytometry for progenitor markers\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — Co-IP demonstrating physical interaction, organoid rescue experiments with HNF1β overexpression; multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"35235779\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Müllerian duct-specific ablation of Hnf1b in mice causes hypoplastic uterine development and kidney anomalies, mirroring Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome type II. Single-cell RNA sequencing of uterine tissue from Hnf1b-ablated embryos reveals dysregulation of cell proliferation, migration, and differentiation pathways downstream of Hnf1b.\",\n      \"method\": \"Müllerian duct epithelium-specific Cre/loxP conditional KO, single-cell RNA sequencing, microarray analysis of patient material\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific conditional KO with defined phenotype plus scRNA-seq pathway analysis; establishes causal mechanism for MRKH\",\n      \"pmids\": [\"36282544\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HNF1B (vHNF1/TCF2/LFB3) is a POU-homeodomain transcription factor that forms homodimers and heterodimers with HNF1α, recruits the histone acetyltransferases CBP and PCAF for transactivation, and directly binds the promoters and enhancers of a broad set of target genes (including FXYD2, CaSR, PKHD1, SOCS3, Twist2, Ngn3, Wnt9b, Gfra1, Etv5, Slc2a2/GLUT2, HNF6, Kreisler/MafB, and others) to control epithelial morphogenesis, cell polarity, tubulogenesis, and metabolic gene programs in kidney, liver, pancreas, and other epithelia during development and adult homeostasis; its loss derepresses SOCS3 (blocking HGF-ERK/STAT3-mediated tubulogenesis), activates a Twist2-TGFβ fibrotic cascade, and disrupts Wnt, FGF, and RA signaling hierarchies essential for organogenesis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"HNF1B (vHNF1/TCF2/LFB3) is a homeodomain transcription factor that orchestrates epithelial morphogenesis, cell polarity, and metabolic gene programs across endoderm- and mesoderm-derived organs during development and adult homeostasis [#5, #23]. It binds DNA as a dimer and forms heterodimers with HNF1\\u03b1, acting as a sequence-specific transcriptional activator [#0, #1]; full transactivation depends on its C-terminal QSP-rich domain and on recruitment of the histone acetyltransferases CBP and PCAF, and MODY5-causing mutations abolish activity either by destroying DNA binding or by uncoupling the factor from these coactivators [#11]. As a developmental master regulator HNF1B sits atop sequential transcriptional cascades \\u2014 it directly activates Hnf6 (driving an Hnf6\\u2192Pdx1 axis), occupies Ngn3 regulatory sequences, and is required for visceral endoderm differentiation, hepatic specification, and pancreatic progenitor formation [#5, #17, #21, #25]; in the hindbrain it integrates retinoic acid, FGF, and Bmp inputs to activate Kreisler/MafB (val) and specify rhombomeres 5/6 [#8, #12, #16, #19]. In the kidney and genitourinary tract HNF1B controls ureteric bud branching, apicobasal polarity, and nephrogenesis by directly regulating Wnt9b, Gfra1, and Etv5 in the Ret pathway, and its M\\u00fcllerian-duct function underlies a MRKH-like phenotype [#23, #26, #34]. It directly governs renal transport genes including FXYD2, the calcium-sensing receptor (CaSR), and PKHD1, linking its loss to hypomagnesemia, disordered calcium handling, and cystic kidney disease [#14, #22, #29]. HNF1B loss is also pathogenic through derepression of normally silenced targets: it represses SOCS3 (whose derepression blocks HGF-driven ERK/STAT3 tubulogenesis) and the EMT regulators Twist2 and SLUG/SNAI2, so that its absence triggers a Twist2\\u2013TGF\\u03b2 fibrotic cascade acting cell-non-autonomously on the interstitium [#18, #27, #30]. Mutations in HNF1B cause MODY5 with associated cystic kidney disease [#11, #14].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"Established the basic molecular identity of HNF1B as a dimeric DNA-binding transcriptional activator that heterodimerizes with HNF1\\u03b1, defining how it engages target promoters.\",\n      \"evidence\": \"In vitro and nuclear-extract heterodimerization assays plus reporter transactivation of the albumin promoter, independently replicated by two labs\",\n      \"pmids\": [\"1673926\", \"1673925\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify in vivo target gene repertoire\", \"Coactivator requirements unresolved\", \"Tissue-specific functions not addressed\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Defined how HNF1B's own expression is controlled, showing its promoter is driven by COUP-TF orphan receptors via octamer-binding proteins rather than the HNF4 input that governs HNF1\\u03b1.\",\n      \"evidence\": \"Promoter deletion, footprinting, reporter and mammalian two-hybrid assays\",\n      \"pmids\": [\"8622679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of COUP-TF regulation not tested\", \"Does not address downstream HNF1B targets\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Mapped a discrete interaction surface (aa 400\\u2013450) through which HNF1B cooperates with CREB/ATF1 for cAMP-responsive transcription, distinguishing inducible from basal transactivation.\",\n      \"evidence\": \"Domain-deletion mutagenesis, mammalian two-hybrid, and reporter assays in kidney cells\",\n      \"pmids\": [\"9671480\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological cAMP targets of this interaction not identified\", \"Single cell-line context\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Showed HNF1B is cell-autonomously essential for visceral endoderm differentiation and sits upstream of HNF4, establishing it as an early endodermal regulator before organogenesis.\",\n      \"evidence\": \"Knockout mouse with ES-cell differentiation and tetraploid complementation, marker in situ hybridization\",\n      \"pmids\": [\"10518495\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Early lethality obscured later organ-specific roles\", \"Direct vs indirect control of HNF4 not resolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstrated multi-organ patterning roles by identifying direct/epistatic targets (pdx1, shh, pax2, wt1, valentino) across kidney, pancreas, liver, and hindbrain.\",\n      \"evidence\": \"Zebrafish insertional mutant plus overexpression with target in situ hybridization and epistasis\",\n      \"pmids\": [\"11731484\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding to most targets not shown\", \"Mammalian conservation tested only later\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined HNF1B as essential for intrahepatic bile duct morphogenesis and hepatocyte metabolic gene regulation through tissue-specific deletion.\",\n      \"evidence\": \"Hepatocyte/bile-duct conditional Cre/loxP knockout with histology and expression profiling\",\n      \"pmids\": [\"11934849\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct target promoters for metabolic genes not mapped\", \"Mechanism of duct morphogenesis defect not resolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Resolved hindbrain segmentation control, showing HNF1B directly binds the Kreisler/MafB S5 element and acts in FGF-dependent synergy to specify r5/r6 while independently repressing r4 identity.\",\n      \"evidence\": \"Transgenic enhancer reporters with binding-site mutagenesis (mouse) and zebrafish genetic/FGF-inhibition epistasis\",\n      \"pmids\": [\"16274963\", \"12835397\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of cooperating r5/r6 factors incomplete\", \"Mechanism of hoxb1a repression not defined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Placed HNF1B within the pancreatic endocrine hierarchy as a Hnf6-dependent factor in ductal precursors that give rise to Ngn3+ endocrine cells.\",\n      \"evidence\": \"Immunohistochemistry and lineage/epistasis analysis in Hnf6-deficient mice\",\n      \"pmids\": [\"14570708\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct Ngn3 regulation shown only later\", \"Single-lab epistasis\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined the molecular basis of MODY5 mutations, distinguishing DNA-binding loss from coactivator (CBP/PCAF) uncoupling and identifying the QSP-rich domain as required for transactivation.\",\n      \"evidence\": \"Mutagenesis, reporter assays, Co-IP with CBP/PCAF, nuclear localization studies, TSA treatment\",\n      \"pmids\": [\"15509593\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genotype-phenotype correlation for specific tissues not addressed\", \"Coactivator recruitment to endogenous loci not shown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Established HNF1B as a signaling integrator that converts RA and FGF/MAPK inputs into hindbrain positional identity.\",\n      \"evidence\": \"Zebrafish genetics with RA treatment and FGF/MAPK manipulation, in situ hybridization, epistasis\",\n      \"pmids\": [\"15342476\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect transcriptional integration not separated\", \"Mammalian relevance not tested here\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Connected HNF1B to cystic kidney disease mechanistically by showing it directly regulates the Pkhd1/ARPKD promoter, whose downregulation produces renal cysts.\",\n      \"evidence\": \"Transgenic mutant and conditional KO mouse kidneys with ChIP/promoter binding for Pkhd1\",\n      \"pmids\": [\"16221171\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Other cystogenic targets not enumerated here\", \"Quantitative contribution of Pkhd1 vs other targets unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Expanded the direct target catalog (DPP4, ACE2, SPP1) and linked HNF1B targets to ovarian clear cell carcinoma.\",\n      \"evidence\": \"Conditional inducible expression system, microarray, and promoter binding-site analysis in HEK293 cells\",\n      \"pmids\": [\"16297991\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cell-line context may not reflect kidney epithelia\", \"Direct binding confirmed only by motif analysis for some targets\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Showed HNF1B is required for early pancreas development and controls regional gut patterning by acting upstream of Ptf1a and other patterning genes.\",\n      \"evidence\": \"Tetraploid-aggregation rescue of null embryos with in situ hybridization and immunohistochemistry\",\n      \"pmids\": [\"15668393\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect Ptf1a control not resolved here\", \"Mechanism of agenesis (proliferation vs specification) addressed later\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined a direct vHNF1\\u2192HNF6\\u2192Pdx1 transcriptional cascade controlling pancreatic precursor generation, anchoring HNF1B atop the endocrine differentiation hierarchy.\",\n      \"evidence\": \"In vitro protein-DNA binding to an Hnf6 intronic enhancer plus electroporation reporters, transgenesis, and Hnf6/Tcf2 KO mice\",\n      \"pmids\": [\"16380477\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cofactors at the Hnf6 enhancer not identified\", \"Pdx1 regulation is downstream/indirect\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Positioned HNF1B downstream of RA, Bmp, and Fgf signals in endoderm to drive endocrine \\u03b2-cell development, refining its role as a signaling node.\",\n      \"evidence\": \"Zebrafish morpholino knockdown, pathway inhibition, RA receptor inhibition, and mRNA overexpression rescue\",\n      \"pmids\": [\"17217944\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets of the integrated signals not mapped\", \"Mammalian validation not in this study\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Revealed a key derepression mechanism in disease: HNF1B directly represses SOCS3, and its loss derepresses SOCS3 to block HGF-driven ERK/STAT3 tubulogenesis.\",\n      \"evidence\": \"Genome-wide ChIP-chip, microarray, KO mouse and dominant-negative cells with SOCS3-knockdown rescue and ERK/STAT3 phosphorylation readouts\",\n      \"pmids\": [\"18077349\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo contribution of SOCS3 derepression to human disease not quantified\", \"Other repressed targets not detailed here\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Mapped the cis-regulatory logic of HNF1B's neural expression, identifying a RARE and T-MARE-containing enhancer and a MAFB feedback loop reinforcing r5/r6 expression.\",\n      \"evidence\": \"Transgenic enhancer reporter mice with site-directed mutagenesis of RARE and T-MARE sites\",\n      \"pmids\": [\"17669392\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Feedback loop dynamics not quantified\", \"Other enhancers controlling non-neural expression not addressed\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified novel HNF1B protein partners (E4F1, ZFP36L1) and showed ZFP36L1 can dampen HNF1B transactivation, hinting at post-translational/cytoplasmic regulation.\",\n      \"evidence\": \"Bacterial two-hybrid screen, GST pull-down, reporter assay, co-localization, Xenopus overexpression\",\n      \"pmids\": [\"18418350\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Interactions found via bacterial two-hybrid without reciprocal in vivo validation\", \"Physiological significance of partners unclear\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Established HNF1B as cell-autonomously required for hepatic specification and endoderm competence to respond to inductive FGF.\",\n      \"evidence\": \"Tetraploid-complemented mouse KO with in vitro FGF responsiveness and zebrafish knockdown, hepatic marker in situ hybridization\",\n      \"pmids\": [\"18635606\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct targets conferring FGF competence not identified\", \"Mechanism linking HNF1B to FGF responsiveness unresolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Linked HNF1B to renal magnesium handling by showing direct FXYD2 promoter transactivation, explaining hypomagnesemia in mutation carriers.\",\n      \"evidence\": \"Luciferase reporter assay with HNF1 site plus clinical cohort magnesium measurements\",\n      \"pmids\": [\"19389850\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous ChIP binding not shown\", \"Single-lab clinical association\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Dissected two HNF1B kidney circuits \\u2014 ureteric bud branching and nephric/Mullerian duct maintenance \\u2014 and identified direct control of Wnt9b initiating nephrogenesis.\",\n      \"evidence\": \"Conditional and mosaic Cre/loxP inactivation with ChIP validation of Wnt9b and expression analysis\",\n      \"pmids\": [\"20040500\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full target set of each circuit not enumerated\", \"Mechanism of duct maintenance incompletely defined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Revealed HNF1B as a genetic modifier of Pax2 haploinsufficiency, with cooperative control of nephron segmentation and ureter smooth muscle differentiation.\",\n      \"evidence\": \"Compound heterozygous mouse genetics with molecular-marker in situ hybridization\",\n      \"pmids\": [\"22511595\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct HNF1B-Pax2 molecular interaction not shown\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Resolved HNF1B's pancreatic roles at cellular resolution \\u2014 progenitor proliferation/survival, duct polarity, acinar differentiation, and direct occupancy of Ngn3 regulatory sequences \\u2014 and identified Glis3 as a downstream target.\",\n      \"evidence\": \"Stage-specific conditional KO models with ChIP at Ngn3 sequences, expression and proliferation/apoptosis assays\",\n      \"pmids\": [\"25715395\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs cofactor-dependent Ngn3 activation not fully resolved\", \"Glis3 regulatory mechanism not detailed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined the cellular mechanism of HNF1B in epithelial morphogenesis \\u2014 cell-cell contacts, apicobasal polarity, mitotic cell rearrangement \\u2014 via direct regulation of Ret-pathway genes Gfra1 and Etv5.\",\n      \"evidence\": \"Ureteric-bud-specific KO with live ex vivo imaging, mRNA-seq, and binding analysis for Gfra1/Etv5\",\n      \"pmids\": [\"29158444\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct polarity-effector targets not fully mapped\", \"Mechanism coupling transcription to cell rearrangement unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Uncovered a cell-non-autonomous fibrotic mechanism: HNF1B directly represses Twist2, and its loss activates a Twist2-EMT network and TGF-\\u03b2 secretion driving interstitial fibrosis without epithelial transdifferentiation.\",\n      \"evidence\": \"HNF1B-deficient mIMCD3 cells, RNA-seq, ChIP for Twist2, Twist2-knockdown rescue, and lineage tracing in mutant mice\",\n      \"pmids\": [\"30097458\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of secreted TGF-\\u03b2 ligands not pinned down\", \"In vivo fibrosis contribution quantification limited\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed HNF1B cooperates with ERR\\u03b3 through convergent genomic binding to control renal reabsorption, linking HNF1B to mitochondrial metabolic gene programs.\",\n      \"evidence\": \"ERR\\u03b3 conditional KO mouse, ChIP-seq co-occupancy, and transcriptomic comparison to HNF1B mutants\",\n      \"pmids\": [\"29735694\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct HNF1B-ERR\\u03b3 physical interaction not confirmed by Co-IP\", \"Co-occupancy vs cooperative activity not fully separated\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrated direct HNF1B activation of CaSR (and Cldn14) in the thick ascending limb, mechanistically linking HNF1B to renal calcium handling, with a binding-defective mutant abolishing activation.\",\n      \"evidence\": \"ChIP-seq, reporter assay, DNA-binding mutant p.Lys156Glu, siRNA knockdown in TAL cells, and kidney-specific KO mouse\",\n      \"pmids\": [\"29561186\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Clinical calcium phenotype in carriers not directly tested here\", \"Regulation of Cldn10b switch mechanism not detailed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified an EZH2\\u2192HNF1B\\u2192SLUG axis in cancer, showing HNF1B represses SNAI2/SLUG via RBBP7 to suppress EMT and is itself silenced by EZH2.\",\n      \"evidence\": \"ChIP-seq, RNA-seq, Co-IP for HNF1B-RBBP7, SLUG reporter, and overexpression/knockdown EMT assays\",\n      \"pmids\": [\"31636385\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab characterization\", \"In vivo tumor relevance of RBBP7 complex not established\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed HNF1B physically and functionally cooperates with MafA and NeuroD1 to activate Slc2a2/Glut2 in \\u03b2-cells via simultaneous binding to promoter and distal enhancer.\",\n      \"evidence\": \"Reporter assays, Co-IP of MafA-NeuroD1-HNF1\\u03b2, ChIP-seq re-analysis, and binding-site mutagenesis\",\n      \"pmids\": [\"34223824\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binary interactions within the trimeric complex not fully resolved\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established HNF1B as sufficient (with cofactors) to specify renal tubular fate in reprogramming, and showed the R295C patient mutation selectively rewires specific target sets rather than globally reducing activity.\",\n      \"evidence\": \"Fibroblast-to-iREC reprogramming, Xenopus ectodermal organoids, WT vs R295C RNA-seq, and CRISPR knockdown in Xenopus\",\n      \"pmids\": [\"36522156\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which R295C selects target subsets unknown\", \"Cofactor requirements for reprogramming not defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrated that a MODY3 HNF1\\u03b1 truncation acts through physical interaction with HNF1B to impair pancreatic differentiation, and that restoring HNF1B function rescues progenitor and \\u03b2-cell formation.\",\n      \"evidence\": \"hiPSC 3D organoids, CRISPR engineering, Co-IP, and HNF1B-overexpression rescue with flow cytometry\",\n      \"pmids\": [\"35235779\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the inhibitory interaction not defined\", \"Extent of rescue in vivo not tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Established HNF1B as causally required for uterine (Mullerian duct) development, providing a mechanism for MRKH type II syndrome.\",\n      \"evidence\": \"Mullerian-duct-specific conditional KO with single-cell RNA-seq and patient material analysis\",\n      \"pmids\": [\"36282544\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct HNF1B targets in Mullerian epithelium not validated by ChIP\", \"Genetic basis in MRKH patients not fully resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How HNF1B mutations selectively rewire distinct target-gene subsets across tissues, and what tissue-specific cofactors dictate its activator-versus-repressor switch, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No unified model linking specific mutations to organ-specific phenotypes\", \"Tissue-specific cofactor codes governing activation vs repression not defined\", \"Structural basis of dimerization-dependent target selection unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 11, 18, 27]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 11, 29]},\n      {\"term_id\": \"GO:0003700\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [11, 20]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [14, 18, 25, 29]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 11, 18, 27]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [5, 6, 13, 21, 23, 26]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [11, 14, 22, 29, 34]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [12, 16, 18, 26]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"HNF1A\", \"CBP\", \"PCAF\", \"CREB\", \"E4F1\", \"ZFP36L1\", \"RBBP7\", \"NEUROD1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}